Amirhossein Sahebkar

Amirhossein Sahebkar

  • Assistant Professor, Department of Medical Biotechnology, School of Medicine Mashhad University of Medical Sciences, Mashhad, Iran
  • Board member, Biotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
  • Board member, Neurogenic Inflammation Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  • Adjunct research fellow, Metabolic Research Centre, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia
  • Member of the Policy Making Council, Universal Scientific Education and Research Network (USERN)

Academic Degrees

  • Doctor of Pharmacy (Pharm.D) 2008

Mashhad University of Medical Sciences, Mashahd, Iran

Thesis: “An investigation of serum antibody titres to heat shock protein 27 (anti-Hsp27) as a biomarker for the detection of acute coronary syndrome.”

  • D of Pharmaceutical Biotechnology

Mashhad University of Medical Sciences, Mashahd, Iran

Thesis: “Preparation and evaluation of nanoliposomes conjugated with apolipoprotein B-100 antibodies as a therapeutic option for serum LDL reduction.”

  • Adjunct Research Fellow

Metabolic Research Centre, School of Medicine and Pharmacology, Royal Perth Hospital, University of Western Australia, Perth, Australia

  • Research Fellowship

Mashhad University of Medical Sciences Research Council, Mashhad, Iran

 

Selected Honors and Awards

  • ESI-listed top 1% highly cited researcher
  • National lead investigator of the European Atherosclerosis Society FHSC committee in Iran
  • Outstanding researcher of the decade in IR IRAN, selected by the Iran Academy of Medical Sciences (Prof. Azizi Prize)
  • Winner of the Razavi Science Prize, awarded to the slected researchers of the Razavi-Khorasan province
  • Outstanding researcher of the Mashhad University of Medical Sciences, Mashhad, Iran, 2013.
  • Outstanding researcher of the Mashhad University of Medical Sciences, Mashhad, Iran, 2014.
  • Outstanding researcher of the Mashhad University of Medical Sciences, Mashhad, Iran, 2016.
  • Highly cited researcher of the Mashhad University of Medical Sciences, Mashhad, Iran (several years).
  • Best paper award in the Mashhad University of Medical Sciences, Mashhad, Iran (several years).
  • Member of the Iran National Elite Foundation.
  • Distinguished researcher (rank #1 in Medical Sciences and rank #2 in all scientific fields) of the year 2017 by the Islamic Science Citation Center (ISC)
  • Second level award from the Iran National Elite Foundation.
  • Recipient of the adjunct research fellowship title from the University of Western Australia, Perth, Australia
  • Winner and first-rank of the 17th national Razi Research Festival on Medical Sciences [health sciences and nutrition section (students), 2010]. This prize is conferred by the country’s senior officials such as president and health minister of the country.
  • Winner of the 22nd national Razi Research Festival on Medical Sciences as a constant member of the Biotechnology Research Center (Research Centers section)
  • Winner of the 23rd national Razi Research Festival on Medical Sciences as a constant member of the Biotechnology Research Center (Research Centers section)
  • Awarded as the best research center of the Razzavi Khorasan province in the national research week (Research Centers section), 2016
  • Awarded as the best research center of the Razzavi Khorasan province in the national research week (Research Centers section), 2017
  • Awarded as the best research center of the Razzavi Khorasan province in the national research week (Research Centers section), 2015
  • Awarded as the best research center of the Mashhad University of Medical Sciences (Research Centers section), 2017
  • Winner of the 22nd national Razi Research Festival on Medical Sciences as a constant member of the Biotechnology Research Center (Research Centers section)
  • Winner of the 23rd national Razi Research Festival on Medical Sciences as a constant member of the Biotechnology Research Center (Research Centers section)
  • Winner of the Iran Academy of Medical Sciences best research center award as a constant member of the Biotechnology Research Center (Professor Hadavi Prize)
  • Winner of the Iran Academy of Medical Sciences best paper award (clinical section)
  • Being awarded as one of the Iranian best students of the year, 2008. This prize is conferred by the country’s senior officials such as president, first vice-president and ministers.
  • First rank graduate student of Pharmacy in the Mashhad University of Medical Sciences, 2007.
  • Winner of the gold medal and first rank Ph.D student of the year (medical section) in the Razavi-Khorasan province. Research week festival is held by the Governor of the province, 2010.
  • Awarded young researcher by the Islamic Educational, Scientific and Cutural Organization (ISESCO).
  • First rank Ph.D student of the year (medical section) in the Razavi-Khorasan province. Research week festival is held by the Governor of the province, 2011.
  • Honored researcher of the year 2008 (Undergraduate students section) in the Mashhad University of Medical Sciences.
  • First-rank researcher of the year 2011 (Postgraduate students section) in the Mashhad University of Medical Sciences.
  • Early Career Researcher Award 2017. Selected by the Elsevier Journal „Complementary Therapies in Medicine”.
  • Winner of the travel grant award, World Congress of Cardiology, 2012.
  • Provincial and national research awards in 2008 and 2009.
  • First rank Ph.D student of the School of Pharmacy of the Mashhad University of Medical Sciences, (several times).
  • Rank 8th of the country in the comprehensive basic sciences exam of pharmacy students, 2005.
  • Collaboration (as the primary colleague) in the awarded research project in the 14th national Razi Research Festival in Medical Sciences (health sciences and nutrition section, 2008).
  • Rank 6th of the country in the 16th national Razi Research Festival on Medical Sciences [Pharmacology section (students), 2010]
  • Member of the Islamic World Young Scientists Academy (IYSA).
  • Best oral presentation at the first national congress of „Medicine and Dedication”, Mashhad, Iran. 2012.
  • First rank in the national “Holy Quran” contest of the Iran medical universities: Research section. 2013.
  • Awarded for the Featured article in the “Holy Quran” contest of the Mashhad University of Medical Sciences, Mashhad, Iran. 2013.
  • Rank 1st in Medical Sciences publications in IRAN and rank 2nd in all scientific fields in Iran, 2016
  • Member of the Lipid and Blood Pressure Meta-analysis Collaboration group which is a multinational and reputed scientific research collaboration group

 

Editorial board membership/activity

  • Phytotherapy Research
  • Complementary Therapies in Medicine
  • Archives of Medical Sciences
  • Archives of Medical Sciences – Atherosclerotic Diseases
  • Recent Patents on Drug Delivery & Formulation
  • World Journal of Translational Medicine
  • Cardiovascular & Hematological Agents in Medicinal Chemistry
  • High Blood Pressure & Cardiovascular Prevention
  • World Journal of Cardiology
  • World Journal of Clinical Cases
  • Pharmanutrition & Functional Food

Patents

Sahebkar A, Badiee A, Jaafari MR. Method and composition for treatment of dyslipidemia and other diseases. US20150147383.

 

 

 

 

 

 

 

 

Peer-reviewed Papers

  1. Abbaszadegan, M.R., et al., Isolation, identification, and characterization of cancer stem cells: A review. Journal of Cellular Physiology, 2017. 232(8): p. 2008-2018.
  2. Abdollahi, E., et al., Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: A nature-made jack-of-all-trades? Journal of Cellular Physiology, 2018. 233(2): p. 830-848.
  3. Abedini, S., A. Sahebkar, and M. Hassanzadeh-Khayyat, Chemical Composition of the Essential Oil of Thymus vulgaris L. Grown in Iran. Journal of Essential Oil-Bearing Plants, 2014. 17(3): p. 538-543.
  4. Aboutorabi, R.B., et al., TRPV1 gene polymorphisms in patients with diabetes compared with healthy individuals. Comparative Clinical Pathology, 2017. 26(4): p. 971-974.
  5. Afkhamizadeh, M., et al., Topical propolis improves wound healing in patients with diabetic foot ulcer: a randomized controlled trial. Natural Product Research, 2017: p. 1-4.
  6. Ahmaditabar, P., et al., Enhanced Entrapment and Improved in Vitro Controlled Release of N-Acetyl Cysteine in Hybrid PLGA/Lecithin Nanoparticles Prepared Using a Nanoprecipitation/Self-Assembly Method. Journal of Cellular Biochemistry, 2017. 118(12): p. 4203-4209.
  7. Akaberi, M., et al., Therapeutic effects of Aloe spp. in traditional and modern medicine: A review. Biomedicine and Pharmacotherapy, 2016. 84: p. 759-772.
  8. Alavi-Shahri, J., et al., Association Between Angiotensin II Type 1 Receptor Gene Polymorphism and Metabolic Syndrome in a Young Female Iranian Population. Archives of Medical Research, 2010. 41(5): p. 343-349.
  9. Ansari, L., et al., The most prevalent side effects of pegylated liposomal doxorubicin monotherapy in women with metastatic breast cancer: A systematic review of clinical trials. Cancer Gene Therapy, 2017. 24(5): p. 189-193.
  10. Aryanpour, R., et al., Simvastatin treatment is not associated with changes in serum concentrations of heat shock proteins -60 and -70 in patients with dyslipidemia. Pharmaceutical Sciences, 2014. 20(2): p. 46-51.
  11. Asgary, S., et al., Improvement of hypertension, endothelial function and systemic inflammation following short-term supplementation with red beet (Beta vulgaris L.) juice: A randomized crossover pilot study. Journal of Human Hypertension, 2016. 30(10): p. 627-632.
  12. Asgary, S., et al., Nigella sativa L. improves lipid profile and prevents atherosclerosis: Evidence from an experimental study on hypercholesterolemic rabbits. Journal of Functional Foods, 2013. 5(1): p. 228-234.
  13. Asgary, S., et al., Investigation of the lipid-modifying and antiinflammatory effects of cornus mas L. supplementation on dyslipidemic children and adolescents. Pediatric Cardiology, 2013. 34(7): p. 1729-1735.
  14. Asgary, S., et al., Clinical investigation of the acute effects of pomegranate juice on blood pressure and endothelial function in hypertensive individuals. ARYA Atherosclerosis, 2013. 9(6): p. 326-331.
  15. Asgary, S., et al., Pomegranate consumption and blood pressure: A review. Current Pharmaceutical Design, 2017. 23(7): p. 1042-1050.
  16. Asgary, S., et al., Serum levels of lead, mercury and cadmium in relation to coronary artery disease in the elderly: A cross-sectional study. Chemosphere, 2017. 180: p. 540-544.
  17. Asgary, S., et al., Essential oils from the fruits and leaves of Juniperus sabina possess inhibitory activity against protein glycation and oxidative stress: An in vitro phytochemical investigation. Journal of Essential Oil Research, 2013. 25(1): p. 70-77.
  18. Asgary, S., et al., Chemical analysis and biological activities of Cupressus sempervirens var. horizontalis essential oils. Pharmaceutical Biology, 2013. 51(2): p. 137-144.
  19. Asgary, S., et al., Inhibition of protein glycation by essential oils of branchlets and fruits of Juniperus communis subsp. hemisphaerica. Research in Pharmaceutical Sciences, 2014. 9(3): p. 179-185.
  20. Asgary, S., et al., Antihyperlipidemic Effects of Sesamum indicum L. in Rabbits Fed a High-Fat Diet. The Scientific World Journal, 2013. 2013.
  21. Asgary, S., et al., Anti-hyperglycemic and anti-hyperlipidemic effects of Vaccinium myrtillus fruit in experimentally induced diabetes (antidiabetic effect of Vaccinium myrtillus fruit). Journal of the Science of Food and Agriculture, 2016. 96(3): p. 764-768.
  22. Asgary, S., et al., Biochemical and histopathological study of the anti-hyperglycemic and anti-hyperlipidemic effects of cornelian cherry (Cornus mas L.) in alloxan-induced diabetic rats. Journal of Complementary and Integrative Medicine, 2014. 11(2): p. 63-69.
  23. Asgary, S., et al., Clinical evaluation of blood pressure lowering, endothelial function improving, hypolipidemic and anti-inflammatory effects of pomegranate juice in hypertensive subjects. Phytotherapy Research, 2014. 28(2): p. 193-199.
  24. Asgary, S., A. Sahebkar, and N. Goli-Malekabadi, Ameliorative effects of Nigella sativa on dyslipidemia. Journal of Endocrinological Investigation, 2015. 38(10): p. 1039-1046.
  25. Asgary, S., et al., Relationship between serum resistin concentrations with metabolic syndrome and its components in an Iranian population. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 2015. 9(4): p. 266-270.
  26. Asili, J., et al., Chemical composition and in vitro efficacy of essential oil of seven Artemisia species against ESBL producing multidrug-resistant Escherichia coli. Journal of Essential Oil-Bearing Plants, 2015. 18(1): p. 124-145.
  27. Asili, J., et al., Identification of essential oil components of ferula badrakema fruits by gc-ms and13c-nmr methods and evaluation of its antimicrobial activity. Journal of Essential Oil-Bearing Plants, 2009. 12(1): p. 7-15.
  28. Assali, A., et al., Association between angiotensin II type-1 receptor A1166C polymorphism and the presence of angiographically-defined coronary artery disease in an Iranian population. Asian Biomedicine, 2010. 4(2): p. 307-314.
  29. Assali, A., et al., Association of angiotensin II type 1 receptor gene A1166C polymorphism with the presence of diabetes mellitus and metabolic syndrome in patients with documented coronary artery disease. European Journal of Internal Medicine, 2011. 22(3): p. 254-261.
  30. Atkin, S.L., et al., Effect of dipeptidyl peptidase-4 inhibitors on circulating tumor necrosis factor-α concentrations: A systematic review and meta-analysis of controlled trials. Journal of Diabetes and its Complications, 2017. 31(9): p. 1458-1464.
  31. Atkin, S.L., et al., Curcuminoids Lower Plasma Leptin Concentrations: A Meta-analysis. Phytotherapy Research, 2017. 31(12): p. 1836-1841.
  32. Ayati, S.H., et al., Regulatory effects of berberine on microRNome in Cancer and other conditions. Critical Reviews in Oncology/Hematology, 2017. 116: p. 147-158.
  33. Azarpazhooh, M.R., et al., Serum high-sensitivity c-reactive protein and heat shock protein 27 antibody titers in patients with stroke and 6-month prognosis. Angiology, 2010. 61(6): p. 607-612.
  34. Azimi-Nezhad, M., et al., Newly detected hypertension in an Iranian population: An epidemiological study. Asian Biomedicine, 2009. 3(6): p. 653-662.
  35. Bacchetti, T., G. Ferretti, and A. Sahebkar, The role of paraoxonase in cancer. Seminars in Cancer Biology, 2017.
  36. Bagheri, S.M., et al., Evaluation of cytotoxicity and anticonvulsant activity of some Iranian medicinal Ferula species. Pharmaceutical Biology, 2010. 48(3): p. 242-246.
  37. Bagheri, V., et al., Cytokine networks and their association with Helicobacter pylori infection in gastric carcinoma. Journal of Cellular Physiology, 2017.
  38. Bagheri, V., et al., Neutralizing human recombinant antibodies against herpes simplex virus type 1 glycoproteins B from a phage-displayed scFv antibody library. Life Sciences, 2017. 169: p. 1-5.
  39. Bagherniya, M., et al., Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review. Pharmacological Research, 2018.
  40. Baghshini, M.R., et al., Higher prevalence of metabolic syndrome among male employees of a gas refinery than in their counterparts in nonindustrial environments. Asian Biomedicine, 2017. 11(3): p. 227-234.
  41. Bała, M., et al., Effects of tibolone on fibrinogen and antithrombin III: A systematic review and meta-analysis of controlled trials. Pharmacological Research, 2017. 124: p. 64-73.
  42. Banach, M., et al., Lipids, blood pressure and kidney update 2014. Pharmacological Research, 2015. 95-96: p. 111-125.
  43. Banach, M., et al., A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in HIV-infected patients. Pharmacological Research, 2016. 111: p. 343-356.
  44. Banach, M., et al., Natural products as the integral part of the therapy? Current Pharmaceutical Design, 2017. 23(17): p. 2411-2413.
  45. Banach, M., et al., Impact of statin therapy on coronary plaque composition: A systematic review and meta-analysis of virtual histology intravascular ultrasound studies. BMC Medicine, 2015. 13(1).
  46. Banach, M., et al., Effects of coenzyme Q10 on statin-induced myopathy: A meta-analysis of randomized controlled trials. Mayo Clinic Proceedings, 2015. 90(1): p. 24-34.
  47. Banach, M., et al., Statin therapy and plasma coenzyme Q10 concentrations – A systematic review and meta-analysis of placebo-controlled trials. Pharmacological Research, 2015. 99: p. 329-336.
  48. Banach, M., et al., Comparison of clinical outcomes between bioresorbable vascular stents versus conventional drug-eluting and metallic stents: A systematic review and meta-analysis. EuroIntervention, 2016. 12(2): p. e175-e189.
  49. Baradari, A.G., et al., Effects of combined prokinetic administration on gastric emptying in critically ill patients. Arab Journal of Gastroenterology, 2017. 18(1): p. 30-34.
  50. Bazzaz, B.S.F., et al., Antimicrobial and antioxidant activities of methanol, dichloromethane and ethyl acetate extracts of Scutellaria lindbergii Rech.f. Chiang Mai Journal of Science, 2013. 40(1): p. 49-59.
  51. Bazzaz, B.S.F., et al., Antioxidant and antimicrobial activity of methanol, dichloromethane, and ethyl acetate extracts of Scutellaria litwinowii. ScienceAsia, 2011. 37(4): p. 327-334.
  52. Beiraghdar, F., et al., Investigation of the efficacy of a biogeneric recombinant human erythropoietin alfa in the management of renal anemia in patients on hemodialysis: A multi-center clinical trial. Clinical Laboratory, 2012. 58(7-8): p. 737-745.
  53. Beiraghdar, F., et al., Evaluation of a biosimilar recombinant alpha epoetin in the management of anemia in hemodialysis patients. Saudi Pharmaceutical Journal, 2015. 23(5): p. 544-548.
  54. Beiraghdar, F., et al., Investigation of the efficacy of a biogeneric recombinant human erythropoietin alfa in the correction of post-transplantation anemia: A randomized comparative trial with eprex. Clinical Laboratory, 2012. 58(11-12): p. 1179-1185.
  55. Bianconi, V., et al., The regulation and importance of monocyte chemoattractant protein-1. Current Opinion in Hematology, 2018. 25(1): p. 44-51.
  56. Bianconi, V., et al., Statins, haemostatic factors and thrombotic risk. Current Opinion in Cardiology, 2017. 32(4): p. 460-466.
  57. Bianconi, V., et al., Endothelial and cardiac progenitor cells for cardiovascular repair: A controversial paradigm in cell therapy. Pharmacology and Therapeutics, 2018. 181: p. 156-168.
  58. Boskabadi, H., et al., Association between serum interleukin-6 levels and severity of perinatal asphyxia. Asian Biomedicine, 2010. 4(1): p. 79-85.
  59. Boskabadi, H., et al., Neonatal hypernatremia and dehydration in infants receiving inadequate breastfeeding. Asia Pacific Journal of Clinical Nutrition, 2010. 19(3): p. 301-307.
  60. Boskabadi, H., et al., Maternal and neonatal serum concentrations of zinc and copper in preterm delivery: An observational study. Trace Elements and Electrolytes, 2012. 29(4): p. 232-238.
  61. Boskabadi, H., et al., Effect of prenatal selenium supplementation on cord blood selenium and lipid profile. Pediatrics and Neonatology, 2012. 53(6): p. 334-339.
  62. Boskabadi, H., et al., The effect of maternal selenium supplementation on pregnancy outcome and the level of oxidative stress in neonates. Iranian Red Crescent Medical Journal, 2010. 12(3): p. 254-259.
  63. Brie, D., et al., Effects of pentoxifylline on inflammatorymarkers and blood pressure: A systematic reviewandmeta-analysis of randomized controlled trials. Journal of Hypertension, 2016. 34(12): p. 2318-2329.
  64. Broncel, M., et al., Sleep changes following statin therapy: A systematic review and meta-analysis of randomized placebo-controlled polysomnographic trials. Archives of Medical Science, 2015. 11(5): p. 915-926.
  65. Chruściel, P., et al., Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms. Atherosclerosis, 2016. 253: p. 194-208.
  66. Cicero, A.F.G., et al., Lipid-lowering nutraceuticals in clinical practice: Position paper from an International Lipid Expert Panel. Nutrition Reviews, 2017. 75(9): p. 731-767.
  67. Cicero, A.F.G., et al., Lipid lowering nutraceuticals in clinical practice: Position paper from an International Lipid Expert Panel. Archives of Medical Science, 2017. 13(5): p. 965-1005.
  68. Cicero, A.F.G., et al., Effects of Allopurinol on Endothelial Function: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. Drugs, 2018. 78(1): p. 99-109.
  69. Dadjo, Y., et al., Effects of supplementation with Heracleum persicum fruit extract on serum lipids in patients undergoing coronary angiography: A pilot trial. Phytotherapy Research, 2015. 29(1): p. 141-143.
  70. De Vincentis, A., et al., Effect of sibutramine on plasma C-reactive protein, leptin and adiponectin concentrations: A systematic review and meta-analysis of randomized controlled trials. Current Pharmaceutical Design, 2017. 23(6): p. 870-878.
  71. Derosa, G., et al., Impact of Statin Therapy on Plasma Uric Acid Concentrations: A Systematic Review and Meta-Analysis. Drugs, 2016. 76(9): p. 947-956.
  72. Derosa, G., et al., Evaluation of BAG3 levels in healthy subjects, hypertensive patients, and hypertensive diabetic patients. Journal of Cellular Physiology, 2018. 233(3): p. 1791-1795.
  73. Derosa, G., P. Maffioli, and A. Sahebkar, Plasma uric acid concentrations are reduced by fenofibrate: A systematic review and meta-analysis of randomized placebo-controlled trials. Pharmacological Research, 2015. 102: p. 63-70.
  74. Derosa, G., P. Maffioli, and A. Sahebkar, Auraptene and its role in chronic diseases, in Advances in Experimental Medicine and Biology. 2016. p. 399-407.
  75. Derosa, G., P. Maffioli, and A. Sahebkar, Ellagic acid and its role in chronic diseases, in Advances in Experimental Medicine and Biology. 2016. p. 473-479.
  76. Derosa, G., P. Maffioli, and A. Sahebkar, Piperine and its role in chronic diseases, in Advances in Experimental Medicine and Biology. 2016. p. 173-184.
  77. Derosa, G., P. Maffioli, and A. Sahebkar, Improvement of plasma adiponectin, leptin and C-reactive protein concentrations by orlistat: A systematic review and meta-analysis. British Journal of Clinical Pharmacology, 2016. 81(5): p. 819-834.
  78. Derosa, G., et al., Effect of curcumin on circulating interleukin-6 concentrations: A systematic review and meta-analysis of randomized controlled trials. Pharmacological Research, 2016. 111: p. 394-404.
  79. Derosa, G., A. Sahebkar, and P. Maffioli, The role of various peroxisome proliferator-activated receptors and their ligands in clinical practice. Journal of Cellular Physiology, 2018. 233(1): p. 153-161.
  80. Dinca, M., et al., Does vitamin D supplementation alter plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials. Pharmacological Research, 2016. 107: p. 360-371.
  81. Dolezelova, E., et al., Effect of ezetimibe on plasma adipokines: a systematic review and meta-analysis. British Journal of Clinical Pharmacology, 2017. 83(7): p. 1380-1396.
  82. Ellis, K.L., et al., The renaissance of lipoprotein(a): Brave new world for preventive cardiology? Progress in Lipid Research, 2017. 68: p. 57-82.
  83. Emami, S.A., et al., Investigation of antioxidant and anti-glycation properties of essential oils from fruits and branchlets of Juniperus oblonga. Brazilian Journal of Pharmacognosy, 2012. 22(5): p. 985-993.
  84. Emami, S.A., et al., Antioxidant activities of Juniperus foetidissima essential oils against several oxidative systems. Brazilian Journal of Pharmacognosy, 2011. 21(4): p. 627-634.
  85. Emami, S.A., A. Sahebkar, and B. Javadi, Paresthesia: A review of its definition, etiology and treatments in view of the traditional medicine. Current Pharmaceutical Design, 2016. 22(3): p. 321-327.
  86. Emami, S.A., et al., Cancer and its treatment in main ancient books of islamic Iranian traditional medicine (7th to 14th century AD). Iranian Red Crescent Medical Journal, 2012. 14(12).
  87. Eslami, S. and A. Sahebkar, Glutathione-S-transferase M1 and T1 null genotypes are associated with hypertension risk: A systematic review and meta-analysis of 12 studies. Current Hypertension Reports, 2014. 16(6).
  88. Esmaeili, S.A., et al., Tolerogenic probiotics: potential immunoregulators in Systemic Lupus Erythematosus. Journal of Cellular Physiology, 2017. 232(8): p. 1994-2007.
  89. Esmaily, H., et al., An investigation of the effects of curcumin on anxiety and depression in obese individuals: A randomized controlled trial. Chinese Journal of Integrative Medicine, 2015. 21(5): p. 332-338.
  90. Fairoozy, R.H., et al., The Genetic Spectrum of Familial Hypercholesterolemia (FH) in the Iranian Population. Scientific Reports, 2017. 7(1).
  91. Farrokhi, F., et al., Effects of statin therapy on serum trace element status in dyslipidemic patients: Results of a randomized placebo-controlled cross-over trial. Clinical Laboratory, 2012. 58(9-10): p. 1005-1015.
  92. Fathullahzadeh, S., et al., Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia. Cancer Gene Therapy, 2016. 23(10): p. 327-332.
  93. Ferretti, G., et al., Impact of Statin Therapy on Plasma MMP-3, MMP-9, and TIMP-1 Concentrations: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. Angiology, 2017. 68(10): p. 850-862.
  94. Ferretti, G., et al., Lipoprotein(a): A missing culprit in the management of athero-thrombosis? Journal of Cellular Physiology, 2017.
  95. Ferretti, G., T. Bacchetti, and A. Sahebkar, Effect of statin therapy on paraoxonase-1 status: A systematic review and meta-analysis of 25 clinical trials. Progress in Lipid Research, 2015. 60: p. 50-73.
  96. Ferretti, G., et al., Raloxifene Lowers Plasma Lipoprotein(a) Concentrations: a Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials. Cardiovascular Drugs and Therapy, 2017. 31(2): p. 197-208.
  97. Ganjali, S., et al., Effects of curcumin on HDL functionality. Pharmacological Research, 2017. 119: p. 208-218.
  98. Ganjali, S., et al., HDL functionality in type 1 diabetes. Atherosclerosis, 2017. 267: p. 99-109.
  99. Ganjali, S., et al., HDL abnormalities in familial hypercholesterolemia: Focus on biological functions. Progress in Lipid Research, 2017. 67: p. 16-26.
  100. Ganjali, S., et al., HDL functionality in familial hypercholesterolemia: effects of treatment modalities and pharmacological interventions. Drug Discovery Today, 2018. 23(1): p. 171-180.
  101. Ganjali, S., et al., Investigation of the effects of curcumin on serum cytokines in obese individuals: A randomized controlled trial. The Scientific World Journal, 2014. 2014.
  102. Ghandadi, M. and A. Sahebkar, Interleukin-6: A critical cytokine in cancer multidrug resistance. Current Pharmaceutical Design, 2016. 22(5): p. 518-526.
  103. Ghandadi, M. and A. Sahebkar, Microrna-34a and its target genes: Key factors in cancer multidrug resistance. Current Pharmaceutical Design, 2016. 22(7): p. 933-939.
  104. Ghandadi, M. and A. Sahebkar, Curcumin: An effective inhibitor of interleukin-6. Current Pharmaceutical Design, 2017. 23(6): p. 921-931.
  105. Ghannad, M.S., et al., Prevalence of hepatitis B and hepatitis C in patients referred to health centers in the Hamadan province, Iran: An epidemiologic study of infections between 2004 and 2007. Asian Biomedicine, 2013. 7(5): p. 619-625.
  106. Ghayour-Mobarhan, M., et al., Determination of Prooxidant—Antioxidant Balance After Acute Coronary Syndrome Using a Rapid Assay: A Pilot Study. Angiology, 2009. 60(6): p. 657-662.
  107. Ghayour-Mobarhan, M., et al., Tocopheryl Phosphate as a Bioactive Derivative of Vitamin E: A Review of the Literature. Journal of Dietary Supplements, 2015. 12(4): p. 359-372.
  108. Ghayour-Mobarhan, M., et al., Antibody titres to heat shock protein 27 are elevated in patients with acute coronary syndrome. International Journal of Experimental Pathology, 2008. 89(3): p. 209-215.
  109. Ghayour-Mobarhan, M., et al., Investigation of the effects of statin therapy on serum vitamin E status in patients with dyslipidemia. Pakistan Journal of Nutrition, 2008. 7(4): p. 561-565.
  110. Ghayour-Mobarhan, M., et al., Investigation of the effect of high dairy diet on body mass index and body fat in overweight and obese children. Indian Journal of Pediatrics, 2009. 76(11): p. 1145-1150.
  111. Ghazimoradi, M., et al., The Effects of Curcumin and Curcumin–Phospholipid Complex on the Serum Pro-oxidant–Antioxidant Balance in Subjects with Metabolic Syndrome. Phytotherapy Research, 2017. 31(11): p. 1715-1721.
  112. Gheibi Hayat, S.M. and A.H. Sahebkar, Antibody drug conjugates for cancer therapy. Journal of Babol University of Medical Sciences, 2017. 19(7): p. 20-27.
  113. Giorgini, P., et al., Comparison of clinical outcomes between genders following antihypertensive therapy: A meta-analysis. Current Medicinal Chemistry, 2017. 24(24): p. 2639-2649.
  114. Goli-Malekabadi, N., et al., The protective effects of Ziziphus vulgaris L. Fruits on biochemical and histological abnormalities induced by diabetes in rats. Journal of Complementary and Integrative Medicine, 2014. 11(3): p. 171-177.
  115. Gorabi, A.M., et al., Cells, Scaffolds and Their Interactions in Myocardial Tissue Regeneration. Journal of Cellular Biochemistry, 2017. 118(8): p. 2454-2462.
  116. Hajavi, J., et al., Curcumin: A Naturally Occurring Modulator of Adipokines in Diabetes. Journal of Cellular Biochemistry, 2017. 118(12): p. 4170-4182.
  117. Hasanzadeh, F., et al., The effect of cold application and lavender oil inhalation in cardiac surgery patients undergoing chest tube removal. EXCLI Journal, 2016. 15: p. 64-74.
  118. Hashemi Goradel, N., et al., Nanoparticles as new tools for inhibition of cancer angiogenesis. Journal of Cellular Physiology, 2017.
  119. Hashemi Goradel, N., et al., Biosensors for the Detection of Environmental and Urban Pollutions. Journal of Cellular Biochemistry, 2018. 119(1): p. 207-212.
  120. Heidari-Bakavoli, A.R., et al., Changes in plasma level of heat shock protein 27 after acute coronary syndrome. Angiology, 2012. 63(1): p. 12-16.
  121. Hoseini, Z., et al., NLRP3 inflammasome: Its regulation and involvement in atherosclerosis. Journal of Cellular Physiology, 2018. 233(3): p. 2116-2132.
  122. Hosseinzadeh, H., et al., Affinity-based target deconvolution of safranal. DARU, Journal of Pharmaceutical Sciences, 2013. 21(1).
  123. Hosseinzadeh, H., et al., Proteomic screening of molecular targets of crocin. DARU, Journal of Pharmaceutical Sciences, 2014. 22(1).
  124. Imenshahidi, M., et al., Hypotensive activity of auraptene, a monoterpene coumarin from Citrus spp. Pharmaceutical Biology, 2013. 51(5): p. 545-549.
  125. Iranshahi, M., et al., Evaluation of antioxidant, anti-inflammatory and lipoxygenase inhibitory activities of the prenylated coumarin umbelliprenin. Daru, 2009. 17(2): p. 99-103.
  126. Iranshahi, M., et al., Drimane-type sesquiterpene coumarins from ferula gummosa fruits enhance doxorubicin uptake in doxorubicin-resistant human breast cancer cell line. Journal of Traditional and Complementary Medicine, 2014. 4(2): p. 118-125.
  127. Iranshahi, M., et al., Can Small Chemical Modifications of Natural Pan-inhibitors Modulate the Biological Selectivity? the Case of Curcumin Prenylated Derivatives Acting as HDAC or mPGES-1 Inhibitors. Journal of Natural Products, 2015. 78(12): p. 2867-2879.
  128. Iranshahi, M., et al., Badrakemonin, a new eremophilane-type sesquiterpene from the roots of Ferula badrakema Kos.-Pol. Iranian Journal of Pharmaceutical Research, 2009. 8(4): p. 275-279.
  129. Iranshahi, M., et al., Chemical Composition of the Fruit Oil of Ferula flabelliloba. Journal of Essential Oil-Bearing Plants, 2008. 11(2): p. 143-147.
  130. Iranshahi, M., et al., Diversivittatin, a new phenylpropanoid derivative from the roots of ferula diversivittata. Chemistry of Natural Compounds, 2010. 46(2): p. 192-194.
  131. Iranshahi, M., et al., New sesquiterpene coumarins from the roots of Ferula flabelliloba. Pharmaceutical Biology, 2010. 48(2): p. 217-220.
  132. Iranshahi, M., et al., Sesquiterpene coumarins from the fruits of Ferula badrakema. Pharmaceutical Biology, 2009. 47(4): p. 344-347.
  133. Iranshahi, M., et al., Cancer chemopreventive activity of diversin from Ferula diversivittata in vitro and in vivo. Phytomedicine, 2010. 17(3-4): p. 269-273.
  134. Iranshahi, M., et al., Cancer chemopreventive activity of the prenylated coumarin, umbelliprenin, in vivo. European Journal of Cancer Prevention, 2009. 18(5): p. 412-415.
  135. Iranshahi, M., et al., Sulfur containing compounds in the volatile oil of ferula latisecta rech. f. & aell. leaves. Journal of Essential Oil-Bearing Plants, 2009. 12(1): p. 64-68.
  136. Jadidi, K., et al., Topical cyclosporine a for treatment of dry eye due to chronic mustard gas injury. Journal of Ophthalmic and Vision Research, 2014. 9(4): p. 417-422.
  137. Jahanbakhsh, S.P., et al., Evaluation of the efficacy of Withania somnifera (Ashwagandha) root extract in patients with obsessive-compulsive disorder: A randomized double-blind placebo-controlled trial. Complementary Therapies in Medicine, 2016. 27: p. 25-29.
  138. Jalali, A., et al., A randomized comparative trial on the efficacy and safety of generic granisetron, kytril and metoclopramide in the prevention of postoperative nausea and vomiting in patients undergoing ophthalmic surgery. Pharmaceutical Sciences, 2014. 20(3): p. 90-95.
  139. Jam, I.N., et al., The effects of crocin on the symptoms of depression in subjects with metabolic syndrome. Advances in Clinical and Experimental Medicine, 2017. 26(6): p. 925-930.
  140. Javadi, B. and A. Sahebkar, Natural products with anti-inflammatory and immunomodulatory activities against autoimmune myocarditis. Pharmacological Research, 2017. 124: p. 34-42.
  141. Javadi, B., A. Sahebkar, and S.A. Emami, A survey on saffron in major Islamic traditional medicine books. Iranian Journal of Basic Medical Sciences, 2013. 16(1): p. 1-11.
  142. Javadi, B., A. Sahebkar, and S.A. Emami, Medicinal plants for the treatment of asthma: A traditional persian medicine perspective. Current Pharmaceutical Design, 2017. 23(11): p. 1623-1632.
  143. Javandoost, A., et al., Effect of crocin, a carotenoid from saffron, on plasma cholesteryl ester transfer protein and lipid profile in subjects with metabolic syndrome: A double blind randomized clinical trial. ARYA Atherosclerosis, 2017. 13(5): p. 245-252.
  144. Johnston, T.P., et al., Preventing cardiovascular heart disease: Promising nutraceutical and non-nutraceutical treatments for cholesterol management. Pharmacological Research, 2017. 120: p. 219-225.
  145. Karamoddini, M.K., et al., Antiviral activities of aerial subsets of Artemisia species against Herpes Simplex virus type 1 (HSV1) in vitro. Asian Biomedicine, 2011. 5(1): p. 63-68.
  146. Kargari, M., et al., Serum anti-HSP27 antibody titers in patients with metabolic syndrome, with or without diabetes mellitus. Comparative Clinical Pathology, 2016. 25(4): p. 895-901.
  147. Karimi, G., et al., Screening of acetylcholinesterase inhibitory activity of terpenoid and coumarin derivatives from the genus Ferula. Pharmacologyonline, 2010. 1: p. 566-574.
  148. Karimian, M.S., et al., Curcumin as a natural regulator of monocyte chemoattractant protein-1. Cytokine and Growth Factor Reviews, 2017. 33: p. 55-63.
  149. Karizbodagh, M.P., et al., Implantation Window and Angiogenesis. Journal of Cellular Biochemistry, 2017. 118(12): p. 4141-4151.
  150. Keihanian, F., et al., Curcumin, hemostasis, thrombosis, and coagulation. Journal of Cellular Physiology, 2017.
  151. Khademi, F., et al., PCSK9 and infection: A potentially useful or dangerous association? Journal of Cellular Physiology, 2017.
  152. Khademi, F., et al., Characterization of clarithromycin-resistant Helicobacter pylori strains in Iran: A systematic review and meta-analysis. Journal of Global Antimicrobial Resistance, 2017. 10: p. 171-178.
  153. Khajeh Karamoddini, M., et al., Antibacterial efficacy of lytic bacteriophages against antibiotic-resistant Klebsiella species. TheScientificWorldJournal, 2011. 11: p. 1332-1340.
  154. Khonche, A., et al., Adjunctive Therapy with Curcumin for Peptic Ulcer: A Randomized Controlled Trial. Drug Research, 2016. 66(8): p. 444-448.
  155. Khoshnevis, M.A., et al., A triage model for chemical warfare casualties. Trauma Monthly, 2015. 20(3).
  156. Kotani, K., et al., Tibolone decreases Lipoprotein(a) levels in postmenopausal women: A systematic review and meta-analysis of 12 studies with 1009 patients. Atherosclerosis, 2015. 242(1): p. 87-96.
  157. Kotani, K., et al., Lipoprotein(a) Levels in Patients with Abdominal Aortic Aneurysm: A Systematic Review and Meta-Analysis. Angiology, 2017. 68(2): p. 99-108.
  158. Lelli, D., C. Pedone, and A. Sahebkar, Curcumin and treatment of melanoma: The potential role of microRNAs. Biomedicine and Pharmacotherapy, 2017. 88: p. 832-834.
  159. Lelli, D., et al., Curcumin use in pulmonary diseases: State of the art and future perspectives. Pharmacological Research, 2017. 115: p. 133-148.
  160. Mahyari, S., et al., Evaluation of the efficacy of a polyherbal mouthwash containing Zingiber officinale, Rosmarinus officinalis and Calendula officinalis extracts in patients with gingivitis: A randomized double-blind placebo-controlled trial. Complementary Therapies in Clinical Practice, 2016. 22: p. 93-98.
  161. Maierean, S., et al., The potential role of mitochondrial ATP synthase inhibitory factor 1 (IF1) in coronary heart disease: a literature review. Lipids in Health and Disease, 2017. 16(1): p. 1-7.
  162. Maierean, S.M., et al., The effects of cinnamon supplementation on blood lipid concentrations: A systematic review and meta-analysis. Journal of Clinical Lipidology, 2017. 11(6): p. 1393-1406.
  163. Mazidi, M., et al., Telomere Length Is Associated With Cardiometabolic Factors in US Adults. Angiology, 2018. 69(2): p. 164-169.
  164. Mazidi, M., et al., Simvastatin treatment does not affect serum vitamin D concentrations in patients with dyslipidemia: A randomized double‑blind placebo‑controlled cross‑over trial. International Journal of Preventive Medicine, 2016. 2016(June).
  165. Mellat, M., et al., Adapting the ICRP model to predict regional deposition of the pharmaceutical aerosols inhaled through DPIs and nebulizers. Journal of Drug Delivery Science and Technology, 2017. 37: p. 81-87.
  166. Michalska-Kasiczak, M., et al., Analysis of vitamin D levels in patients with and without statin-associated myalgia – A systematic review and meta-analysis of 7 studies with 2420 patients. International Journal of Cardiology, 2015. 178: p. 111-116.
  167. Mirzaei, H., et al., MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma. European Journal of Cancer, 2016. 53: p. 25-32.
  168. Mirzaei, H., et al., MicroRNA: A novel target of curcumin in cancer therapy. Journal of Cellular Physiology, 2017.
  169. Mirzaei, H., et al., MicroRNA: Relevance to stroke diagnosis, prognosis, and therapy. Journal of Cellular Physiology, 2018. 233(2): p. 856-865.
  170. Mirzaei, H., et al., Curcumin: A new candidate for melanoma therapy? International Journal of Cancer, 2016. 139(8): p. 1683-1695.
  171. Mirzaei, H., et al., Application of mesenchymal stem cells in melanoma: A potential therapeutic strategy for delivery of targeted agents. Current Medicinal Chemistry, 2016. 23(5): p. 455-463.
  172. Mirzaei, H., et al., Diagnostic and Therapeutic Potential of Exosomes in Cancer: The Beginning of a New Tale? Journal of Cellular Physiology, 2017. 232(12): p. 3251-3260.
  173. Mirzaei, H., et al., PiggyBac as a novel vector in cancer gene therapy: Current perspective. Cancer Gene Therapy, 2016. 23(2-3): p. 45-47.
  174. Mirzaei, H., et al., Boron neutron capture therapy: Moving toward targeted cancer therapy. Journal of Cancer Research and Therapeutics, 2016. 12(2): p. 520-525.
  175. Mirzaei, H., et al., Therapeutic application of multipotent stem cells. Journal of Cellular Physiology, 2017.
  176. Mirzaei, H., et al., Deciphering biological characteristics of tumorigenic subpopulations in human colorectal cancer reveals cellular plasticity. Journal of Research in Medical Sciences, 2016. 21(4).
  177. Mirzaei, H., et al., Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies. Biomedicine and Pharmacotherapy, 2017. 85: p. 102-112.
  178. Mirzaei, H.R., et al., Circulating micrornas in hepatocellular carcinoma: Potential diagnostic and prognostic biomarkers. Current Pharmaceutical Design, 2016. 22(34): p. 5257-5269.
  179. Mirzaei, M., et al., Phylogenetic Analysis of Selected Menthol-Producing Species Belonging to the Lamiaceae Family. Nucleosides, Nucleotides and Nucleic Acids, 2015. 34(9): p. 650-657.
  180. Moallem, S.A., et al., Antiemetic activity of different extracts from the Aerial parts of Thymus transcaspicus Klokov. Pharmacologyonline, 2009. 1: p. 1284-1292.
  181. Modarres, M., et al., Simultaneous determination of rosmarinic acid, salvianolic acid B and caffeic acid in Salvia leriifolia Benth. root, leaf and callus extracts using a high-performance liquid chromatography with diode-array detection technique. Journal of Liquid Chromatography and Related Technologies, 2014. 37(12): p. 1721-1730.
  182. Mohajer, A., et al., Effects of supplementation with curcuminoids on serum copper and zinc concentrations and superoxide dismutase enzyme activity in obese subjects. Trace Elements and Electrolytes, 2014. 32(1): p. 16-21.
  183. Mohajeri, M., et al., Protective effects of curcumin against aflatoxicosis: A comprehensive review. Journal of Cellular Physiology, 2018. 233(4): p. 3552-3577.
  184. Mohajeri, M., M. Rezaee, and A. Sahebkar, Cadmium-induced toxicity is rescued by curcumin: A review. BioFactors, 2017. 43(5): p. 645-661.
  185. Mohamadpour, A.H., et al., Serum osteopontin concentrations in relation to coronary artery disease. Archives of Medical Research, 2015. 46(2): p. 112-117.
  186. Mohammadi, A., et al., Modulatory effects of curcumin on apoptosis and cytotoxicity-related molecules in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients. Biomedicine and Pharmacotherapy, 2017. 85: p. 457-462.
  187. Mohammadi, A., et al., Effects of Curcumin on Serum Vitamin E Concentrations in Individuals with Metabolic Syndrome. Phytotherapy Research, 2017. 31(4): p. 657-662.
  188. Mohammadi, A., et al., Effects of supplementation with curcuminoids on dyslipidemia in obese patients: A randomized crossover trial. Phytotherapy Research, 2013. 27(3): p. 374-379.
  189. Mohammadi, A., et al., Barberry administration and pro-oxidant–antioxidant balance in patients with metabolic syndrome. Iranian Red Crescent Medical Journal, 2014. 16(12).
  190. Mohammadpour, A.H., et al., Evaluation of serum cathepsin D concentrations in coronary artery disease. Indian Heart Journal, 2018.
  191. Mokhber, N., et al., Effect of supplementation with selenium on postpartum depression: A randomized double-blind placebo-controlled trial. Journal of Maternal-Fetal and Neonatal Medicine, 2011. 24(1): p. 104-108.
  192. Mokhtarifar, A., et al., The effect of Portulaca oleracea (purslane) seeds on hemoglobin levels in adolescent girls with iron deficiency anemia: a randomized comparative trial. Comparative Clinical Pathology, 2017. 26(1): p. 11-16.
  193. Momtazi, A.A., et al., Phytochemical Analysis and Cytotoxicity Evaluation of Kelussia odoratissima Mozaff. JAMS Journal of Acupuncture and Meridian Studies, 2017. 10(3): p. 180-186.
  194. Momtazi, A.A., et al., Regulation of PCSK9 by nutraceuticals. Pharmacological Research, 2017. 120: p. 157-169.
  195. Momtazi, A.A., et al., PCSK9 and diabetes: is there a link? Drug Discovery Today, 2017. 22(6): p. 883-895.
  196. Momtazi, A.A., et al., MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia? Clinical Reviews in Allergy and Immunology, 2017: p. 1-10.
  197. Momtazi, A.A., M. Banach, and A. Sahebkar, PCSK9 inhibitors in sepsis: a new potential indication? Expert Opinion on Investigational Drugs, 2017. 26(2): p. 137-139.
  198. Momtazi, A.A., et al., Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases. Molecular Diagnosis and Therapy, 2016. 20(4): p. 335-345.
  199. Momtazi, A.A. and A. Sahebkar, Difluorinated curcumin: A promising curcumin analogue with improved anti-tumor activity and pharmacokinetic profile. Current Pharmaceutical Design, 2016. 22(28): p. 4386-4397.
  200. Momtazi, A.A., et al., Curcumin as a MicroRNA regulator in cancer: A review, in Reviews of Physiology, Biochemistry and Pharmacology. 2016. p. 1-38.
  201. Momtazi-borojeni, A.A., et al., The novel role of pyrvinium in cancer therapy. Journal of Cellular Physiology, 2017.
  202. Momtazi-Borojeni, A.A., et al., A review on the pharmacology and toxicology of steviol glycosides extracted from Stevia rebaudiana. Current Pharmaceutical Design, 2017. 23(11): p. 1616-1622.
  203. Momtazi-Borojeni, A.A., et al., Curcumin: A natural modulator of immune cells in systemic lupus erythematosus. Autoimmunity Reviews, 2017.
  204. Moohebati, M., et al., Simvastatin treatment reduces heat shock protein 60, 65, and 70 antibody titers in dyslipidemic patients: A randomized, double-blind, placebo-controlled, cross-over trial. Clinical Biochemistry, 2011. 44(2-3): p. 192-197.
  205. Moohebati, M., et al., Investigation of serum oxidized low-density lipoprotein IgG levels in patients with angiographically defined coronary artery disease. International Journal of Vascular Medicine, 2014. 2014.
  206. Moohebati, M., et al., Investigation of the effect of short-term supplementation with curcuminoids on circulating small dense low-density lipoprotein concentrations in obese dyslipidemic subjects: A randomized double-blind placebo-controlled cross-over trial. ARYA Atherosclerosis, 2014. 10(5).
  207. Moradzadeh, M., et al., Epigallocatechin-3-gallate enhances differentiation of acute promyelocytic leukemia cells via inhibition of PML-RARα and HDAC1. Phytotherapy Research, 2017.
  208. Moradzadeh, M., et al., Anti-tumor effects of crocetin and related molecular targets. Journal of Cellular Physiology, 2018. 233(3): p. 2170-2182.
  209. Moradzadeh, M., et al., Kaempferol increases apoptosis in human acute promyelocytic leukemia cells and inhibits multidrug resistance genes. Journal of Cellular Biochemistry, 2018. 119(2): p. 2288-2297.
  210. Moridikia, A., et al., MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer. Journal of Cellular Physiology, 2018. 233(2): p. 901-913.
  211. Mousavi, Z., et al., The relationship between serum levels of fibroblast growth factor 21 and diabetic retinopathy. EXCLI Journal, 2017. 16: p. 1249-1256.
  212. Nematy, M., et al., Prevalence of obesity and its association with socioeconomic factors in elderly Iranians from Razavi-Khorasan Province. TheScientificWorldJournal, 2009. 9: p. 1286-1293.
  213. Nikbakht-Jam, I., et al., Effect of crocin extracted from saffron on pro-oxidant–anti-oxidant balance in subjects with metabolic syndrome: A randomized, placebo-controlled clinical trial. European Journal of Integrative Medicine, 2015. 8(3): p. 307-312.
  214. Oladi, M.R., et al., Glucokinase gene promoter-30G>A polymorphism: A cross-sectional association study with obesity, diabetes Mellitus, hyperlipidemia, hypertension and metabolic syndrome in an Iranian hospital. Revista de Nutricao, 2012. 25(4): p. 487-495.
  215. Paciullo, F., et al., PCSK9 at the crossroad of cholesterol metabolism and immune function during infections. Journal of Cellular Physiology, 2017. 232(9): p. 2330-2338.
  216. Panahi, Y., A.H. Abdolghaffari, and A. Sahebkar, A review on symptoms, treatments protocols, and proteomic profile in sulfur mustard-exposed victims. Journal of Cellular Biochemistry, 2018. 119(1): p. 197-206.
  217. Panahi, Y., et al., Curcumin as a potential candidate for treating hyperlipidemia: A review of cellular and metabolic mechanisms. Journal of Cellular Physiology, 2018. 233(1): p. 141-152.
  218. Panahi, Y., et al., Investigation of the effectiveness of Syzygium aromaticum, Lavandula angustifolia and Geranium robertianum essential oils in the treatment of acute external otitis: A comparative trial with ciprofloxacin. Journal of Microbiology, Immunology and Infection, 2014. 47(3): p. 211-216.
  219. Panahi, Y., et al., Efficacy of Elaeagnus angustifolia extract in the treatment of knee osteoarthritis: A randomized controlled trial. EXCLI Journal, 2016. 15: p. 203-210.
  220. Panahi, Y., et al., Mitigation of Systemic Oxidative Stress by Curcuminoids in Osteoarthritis: Results of a Randomized Controlled Trial. Journal of Dietary Supplements, 2016. 13(2): p. 209-220.
  221. Panahi, Y., et al., Effect of aloe vera and pantoprazole on Gastroesophageal reflux symptoms in mustard gas victims: A randomized controlled trial. Pharmaceutical Sciences, 2016. 22(3): p. 190-194.
  222. Panahi, Y., et al., Oral health status among Iranian veterans exposed to sulfur mustard: A case-control study. Journal of Clinical and Experimental Dentistry, 2015. 7(2): p. e192-e196.
  223. Panahi, Y., et al., A randomized controlled trial of 6-week Chlorella vulgaris supplementation in patients with major depressive disorder. Complementary Therapies in Medicine, 2015. 23(4): p. 598-602.
  224. Panahi, Y., et al., Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder. Phytotherapy Research, 2015. 29(1): p. 17-21.
  225. Panahi, Y., et al., A herbal cream consisting of Aloe vera, Lavandulastoechas, and Pelargonium roseum as an alternative for silver sulfadiazine in burn management. Asian Biomedicine, 2012. 6(2): p. 273-278.
  226. Panahi, Y., et al., Environmental toxicant exposure and cancer: The role of epigenetic changes and protection by phytochemicals. Current Pharmaceutical Design, 2015. 22(2): p. 130-140.
  227. Panahi, Y., et al., Serum levels of fibroblast growth factor 21 in type 2 diabetic patients. Acta Endocrinologica, 2016. 12(3): p. 257-261.
  228. Panahi, Y., et al., Clinical evaluation of the anti-inflammatory effects of Heracleum persicum fruits. Comparative Clinical Pathology, 2015. 24(4): p. 971-974.
  229. Panahi, Y., et al., Antioxidant activity of heracleum persicum fruit extract: Evidence from a randomized controlled trial. Journal of Dietary Supplements, 2016. 13(5): p. 530-537.
  230. Panahi, Y., et al., Chlorella vulgaris: A multifunctional dietary supplement with diverse medicinal properties. Current Pharmaceutical Design, 2015. 22(2): p. 164-173.
  231. Panahi, Y., et al., Serum levels of interleukins 2, 4, 6, and 10 in veterans with chronic sulfur mustard-induced pruritus: a cross-sectional study. Skinmed, 2013. 11(4): p. 205-209.
  232. Panahi, Y., et al., Relationship between levels of IFNγ, TNFα, and TGFβ and pruritus in sulfur mustard-exposed veterans. Journal of Immunotoxicology, 2013. 10(2): p. 173-177.
  233. Panahi, Y., et al., Efficacy of Aloe vera/olive oil cream versus betamethasone cream for chronic skin lesions following sulfur mustard exposure: A randomized double-blind clinical trial. Cutaneous and Ocular Toxicology, 2012. 31(2): p. 95-103.
  234. Panahi, Y., et al., Tear total protein analysis in patients with late sulfur mustard-induced ocular complications: A cross-sectional study. Cutaneous and Ocular Toxicology, 2012. 31(2): p. 104-110.
  235. Panahi, Y., et al., Investigation of the effects of Chlorella vulgaris supplementation in patients with non-alcoholic fatty liver disease: A randomized clinical trial. Hepato-Gastroenterology, 2012. 59(119): p. 2099-2103.
  236. Panahi, Y., et al., Short-term Curcuminoid Supplementation for Chronic Pulmonary Complications due to Sulfur Mustard Intoxication: Positive Results of a Randomized Double-blind Placebo-controlled Trial. Drug Research, 2014. 65(11): p. 567-573.
  237. Panahi, Y., et al., Investigation of the efficacy of generic and brand-name tiotropium bromide in the management of chronic obstructive pulmonary disease: A randomized comparative trial. Saudi Pharmaceutical Journal, 2016. 24(2): p. 147-152.
  238. Panahi, Y., et al., Effects of Curcuminoids-Piperine Combination on Systemic Oxidative Stress, Clinical Symptoms and Quality of Life in Subjects with Chronic Pulmonary Complications Due to Sulfur Mustard: A Randomized Controlled Trial. Journal of Dietary Supplements, 2016. 13(1): p. 93-105.
  239. Panahi, Y., et al., Potential utility of N-acetylcysteine for treating mustard lung. Critical Reviews in Eukaryotic Gene Expression, 2017. 27(3): p. 247-266.
  240. Panahi, Y., et al., TGF-β and Th17 cells related injuries in patients with sulfur mustard exposure. Journal of Cellular Physiology, 2017.
  241. Panahi, Y., et al., Effect of recombinant human IFNγ in the treatment of chronic pulmonary complications due to sulfur mustard intoxication. Journal of Immunotoxicology, 2014. 11(1): p. 72-77.
  242. Panahi, Y., et al., Efficacy of probiotic supplementation on quality of life and pulmonary symptoms due to sulfur mustard exposure: a randomized double-blind placebo-controlled trial. Drug and Chemical Toxicology, 2017. 40(1): p. 24-29.
  243. Panahi, Y., et al., Evaluation of the pharmacoeconomics of drugs used for the treatment of long-term complications of sulfur mustard. Italian Journal of Medicine, 2017. 11(2): p. 102-113.
  244. Panahi, Y., et al., Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis. Clinical Nutrition, 2015. 34(6): p. 1101-1108.
  245. Panahi, Y., et al., Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: A post-hoc analysis of a randomized controlled trial. Biomedicine and Pharmacotherapy, 2016. 82: p. 578-582.
  246. Panahi, Y., et al., Effects of supplementation with curcumin on serum adipokine concentrations: A randomized controlled trial. Nutrition, 2016. 32(10): p. 1116-1122.
  247. Panahi, Y., et al., Comparative trial of Aloe vera/ olive oil combination cream versus phenytoin cream in the treatment of chronic wounds. Journal of Wound Care, 2015. 24(10): p. 459-465.
  248. Panahi, Y., et al., Immunology of chronic obstructive pulmonary disease and Sulfur mustard induced airway injuries: Implications for immunotherapeutic interventions. Current Pharmaceutical Design, 2016. 22(20): p. 2975-2996.
  249. Panahi, Y., et al., Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome: Results of a randomized controlled trial. Complementary Therapies in Medicine, 2014. 22(5): p. 851-857.
  250. Panahi, Y., et al., Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial. Inflammopharmacology, 2017. 25(1): p. 25-31.
  251. Panahi, Y., et al., Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial. Complementary Therapies in Medicine, 2017. 33: p. 1-5.
  252. Panahi, Y., et al., Efficacy and safety of Aloe vera syrup for the treatment of gastroesophageal reflux disease: a pilot randomized positive-controlled trial. Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan / sponsored by All-China Association of Traditional Chinese Medicine, Academy of Traditional Chinese Medicine, 2015. 35(6): p. 632-636.
  253. Panahi, Y., et al., Curcumin Lowers Serum Lipids and Uric Acid in Subjects with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial. Journal of Cardiovascular Pharmacology, 2016. 68(3): p. 223-229.
  254. Panahi, Y., et al., Efficacy and Safety of Phytosomal Curcumin in Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial. Drug Research, 2017. 67(4): p. 244-251.
  255. Panahi, Y., et al., A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder. Psychological Medicine, 2011. 41(10): p. 2159-2166.
  256. Panahi, Y., et al., The role of magnesium sulfate in the intensive care unit. EXCLI Journal, 2017. 16: p. 464-482.
  257. Panahi, Y., et al., Investigation of the effects of Chlorella vulgaris supplementation on the modulation of oxidative stress in apparently healthy smokers. Clinical Laboratory, 2013. 59(5-6): p. 579-587.
  258. Panahi, Y., et al., Myrtus communis essential oil for the treatment of hemorrhoids: A randomized double-blind double-dummy parallel-group comparative study. Turkish Journal of Pharmaceutical Sciences, 2014. 11(1): p. 1-8.
  259. Panahi, Y., et al., Results of a randomized, open-label, clinical trial investigating the effects of supplementation with Heracleum persicum extract as an adjunctive therapy for dyslipidemia. TheScientificWorldJournal, 2011. 11: p. 592-601.
  260. Panahi, Y., et al., Efficacy and safety of Dorocontin® versus Sustac® in the treatment of stable Angina Pectoris: A randomized, double-blind comparative trial. Scientia Pharmaceutica, 2014. 82(4): p. 815-824.
  261. Panahi, Y., et al., Investigation of the effects of Chlorella vulgaris as an adjunctive therapy for dyslipidemia: Results of a randomised open-label clinical trial. Nutrition and Dietetics, 2012. 69(1): p. 13-19.
  262. Panahi, Y., et al., Curcuminoid treatment for knee osteoarthritis: A randomized double-blind placebo-controlled trial. Phytotherapy Research, 2014. 28(11): p. 1625-1631.
  263. Panahi, Y., S.M. Rajaee, and A. Sahebkar, Ocular Effects of Sulfur Mustard and Therapeutic Approaches. Journal of Cellular Biochemistry, 2017. 118(11): p. 3549-3560.
  264. Panahi, Y., et al., Sulfur mustard-induced ocular injuries: Update on mechanisms and management. Current Pharmaceutical Design, 2017. 23(11): p. 1589-1597.
  265. Panahi, Y., et al., Antioxidant effects of bioavailability-enhanced curcuminoids in patients with solid tumors: A randomized double-blind placebo-controlled trial. Journal of Functional Foods, 2014. 6(1): p. 615-622.
  266. Panahi, Y., et al., Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: A randomized double-blind placebo-controlled trial. Phytotherapy Research, 2014. 28(10): p. 1461-1467.
  267. Panahi, Y., et al., Efficacy and safety of a biogeneric recombinant human erythropoietin in the management of chemotherapy-induced anemia: a randomized double-blind active-comparator trial. Comparative Clinical Pathology, 2016. 25(1): p. 155-160.
  268. Panahi, Y., et al., Effect of ginger on acute and delayed chemotherapy-induced nausea and vomiting: A pilot, randomized, open-label clinical trial. Integrative Cancer Therapies, 2012. 11(3): p. 204-211.
  269. Panahi, Y., et al., Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: Results of a randomised, double-blind, placebo-controlled trial. British Journal of Nutrition, 2012. 108(7): p. 1272-1279.
  270. Panahi, Y., et al., Efficacy and safety of immunotherapy with interferon-gamma in the management of chronic sulfur mustard-induced cutaneous complications: Comparison with topical betamethasone 1%. The Scientific World Journal, 2012. 2012.
  271. Panahi, Y., et al., A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications. Annals of Clinical Biochemistry, 2012. 49(6): p. 580-588.
  272. Panahi, Y., et al., Atorvastatin therapy is not associated with slowing the progression of aortic stenosis: Findings of a randomized controlled trial. Clinical Laboratory, 2013. 59(3-4): p. 299-305.
  273. Panahi, Y., et al., Management of sulfur mustard-induced chronic pruritus: A review of clinical trials. Cutaneous and Ocular Toxicology, 2012. 31(3): p. 220-225.
  274. Panahi, Y., et al., A randomized comparative trial on the therapeutic efficacy of topical aloe vera and calendula officinalis on diaper dermatitis in children. The Scientific World Journal, 2012. 2012.
  275. Panahi, Y., et al., Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial. Skinmed, 2015. 13(1): p. 15-21.
  276. Panahi, Y., et al., Investigation of serum substance P status in patients with chronic pruritic skin lesions due to sulfur mustard: A cross-sectional study. Cutaneous and Ocular Toxicology, 2013. 32(1): p. 4-8.
  277. Panahi, Y., et al., Impact of adjunctive therapy with Chlorella vulgaris extract on antioxidant status, pulmonary function, and clinical symptoms of patients with obstructive pulmonary diseases. Scientia Pharmaceutica, 2012. 80(3): p. 719-730.
  278. Panahi, Y., et al., Validation of a high-performance liquid chromatography method for the determination of pyridostigmine in plasma. Asian Biomedicine, 2013. 7(2): p. 275-279.
  279. Parizadeh, M.R., et al., Prooxidant-antioxidant balance in stroke patients and 6-month prognosis. Clinical Laboratory, 2011. 57(3-4): p. 183-191.
  280. Parizadeh, S.M.R., et al., Simvastatin therapy reduces prooxidant-antioxidant balance: Results of a placebo-controlled cross-over trial. Lipids, 2011. 46(4): p. 333-340.
  281. Pirro, M., et al., Hepatitis C virus and proprotein convertase subtilisin/kexin type 9: a detrimental interaction to increase viral infectivity and disrupt lipid metabolism. Journal of Cellular and Molecular Medicine, 2017. 21(12): p. 3150-3161.
  282. Pirro, M., et al., Lipoprotein(a) and inflammation: A dangerous duet leading to endothelial loss of integrity. Pharmacological Research, 2017. 119: p. 178-187.
  283. Pirro, M., et al., Uric acid and bone mineral density in postmenopausal osteoporotic women: the link lies within the fat. Osteoporosis International, 2017. 28(3): p. 973-981.
  284. Pirro, M., et al., The effects of a nutraceutical combination on plasma lipids and glucose: A systematic review and meta-analysis of randomized controlled trials. Pharmacological Research, 2016. 110: p. 76-88.
  285. Pirro, M., et al., Urinary albumin-To-creatinine ratio is associated with endothelial dysfunction in HIV-infected patients receiving antiretroviral therapy. Scientific Reports, 2016. 6.
  286. Pourghadamyari, H., et al., Serum antibody titers against heat shock protein 27 are associated with the severity of coronary artery disease. Cell Stress and Chaperones, 2011. 16(3): p. 309-316.
  287. Rahimi, V.B., et al., Comparison of honey and dextrose solution on post-operative peritoneal adhesion in rat model. Biomedicine and Pharmacotherapy, 2017. 92: p. 849-855.
  288. Rahimnia, A.R., et al., Impact of supplementation with curcuminoids on systemic inflammation in patients with knee osteoarthritis: Findings from a randomized double-blind placebo-controlled trial. Drug Research, 2014. 65(10): p. 521-525.
  289. Rahmani, S., et al., Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial. Phytotherapy Research, 2016: p. 1540-1548.
  290. Rahsepar, A.A., et al., Malondialdehyde-Modified LDL IgG Antibody Levels and Indices of Cardiac Function in Valvular Heart and Coronary Artery Disease Patients. Medical Principles and Practice, 2015. 24(5): p. 424-431.
  291. Rajabi-Mashhadi, M.T., et al., Optimum duration of perioperative antibiotic therapy in patients with acute non-perforated appendicitis: A prospective randomized trial. Asian Biomedicine, 2012. 6(6): p. 891-894.
  292. Ramezani, M., M. Hatamipour, and A. Sahebkar, Promising anti-tumor properties of bisdemethoxycurcumin: A naturally occurring curcumin analogue. Journal of Cellular Physiology, 2018. 233(2): p. 880-887.
  293. Rashidi, B., et al., Anti-Atherosclerotic Effects of Vitamins D and E in Suppression of Atherogenesis. Journal of Cellular Physiology, 2017. 232(11): p. 2968-2976.
  294. Razavi-Azarkhiavi, K., et al., The Protective Role of Phenolic Compounds Against Doxorubicin-induced Cardiotoxicity: A Comprehensive Review. Nutrition and Cancer, 2016. 68(6): p. 892-917.
  295. Rezaee, R., et al., Curcumin: A potentially powerful tool to reverse cisplatin-induced toxicity. Pharmacological Research, 2017. 117: p. 218-227.
  296. Riazi, A., et al., The impact of saffron (Crocus sativus) supplementation on visual function in patients with dry age-related macular degeneration. Italian Journal of Medicine, 2017. 11(2): p. 196-201.
  297. Ricciuti, B., et al., Enzymes involved in tumor-driven angiogenesis: A valuable target for anticancer therapy. Seminars in Cancer Biology, 2017.
  298. Ricciuti, B., et al., Emerging enzymatic targets controlling angiogenesis in cancer: preclinical evidence and potential clinical applications. Medical Oncology, 2018. 35(1).
  299. Ruscica, M., et al., Appropriateness of statin prescription in the elderly. European Journal of Internal Medicine, 2018.
  300. Rysz-Górzynska, M., et al., Efficacy of Statin Therapy in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis. Scientific Reports, 2016. 6.
  301. Saadat, S.H., et al., Systematic review and meta-analysis of flibanserin’s effects and adverse events in women with hypoactive sexual desire disorder. Current Drug Metabolism, 2017. 18(1): p. 78-85.
  302. Saadatpour, Z., et al., Molecular imaging and cancer gene therapy. Cancer Gene Therapy, 2016.
  303. Saadatpour, Z., et al., Imaging techniques: New avenues in cancer gene and cell therapy. Cancer Gene Therapy, 2017. 24(1): p. 1-5.
  304. Saberi Karimian, M., M. Ghayour-Mobarhan, and A. Sahebkar, Clinical evaluation of the effects of supplementation with curcuminoids on serum fetuin-B concentrations in obese subjects. Comparative Clinical Pathology, 2016. 25(3): p. 525-530.
  305. Sabouri, S., et al., Association between 45T/G polymorphism of adiponectin gene and coronary artery disease in an iranian population. TheScientificWorldJournal, 2011. 11: p. 93-101.
  306. Sabouri-Rad, S., et al., Ginseng in dermatology: A review. Current Pharmaceutical Design, 2017. 23(11): p. 1649-1666.
  307. Sadeghi, Z., et al., Evaluation the ethno-pharmacological studies in Iran during 2004–2016: A systematic review. Journal of Cellular Physiology, 2018. 233(2): p. 914-923.
  308. Safarian, M., et al., Effect of a high dairy diet on serum antibody titers to heat shock protein 27 in overweight and obese children. Iranian Journal of Pediatrics, 2009. 19(1): p. 41-46.
  309. Sahebari, M., et al., Serum Trace Element Concentrations in Rheumatoid Arthritis. Biological Trace Element Research, 2016. 171(2): p. 237-245.
  310. Sahebari, M., et al., Investigation of the association between metabolic syndrome and disease activity in rheumatoid arthritis. TheScientificWorldJournal, 2011. 11: p. 1195-1205.
  311. Sahebkar, A., Neuroprotective effects of resveratrol: Potential mechanisms. Neurochemistry International, 2010. 57(6): p. 621-622.
  312. Sahebkar, A., Molecular mechanisms for curcumin benefits against ischemic injury. Fertility and Sterility, 2010. 94(5): p. e75-e76.
  313. Sahebkar, A., Citrus auraptene: A potential multifunctional therapeutic agent for nonalcoholic fatty liver disease. Annals of Hepatology, 2011. 10(4): p. 575-577.
  314. Sahebkar, A., Metabolic improvement by telmisartan beyond angiotensin receptor blockade: Role of adipokines. Arquivos Brasileiros de Endocrinologia e Metabologia, 2011. 55(5): p. 353-354.
  315. Sahebkar, A., Potential benefits of supplementation with auraptene in cystic fibrosis. Clinical Nutrition, 2011. 30(2): p. 259-260.
  316. Sahebkar, A., Phosphatidylcholine-rich nanoliposomes: Potential tools for serum C-Reactive protein reduction? Cardiovascular Drugs and Therapy, 2011. 25(1): p. 105-106.
  317. Sahebkar, A., Potential efficacy of ginger as a natural supplement for nonalcoholic fatty liver disease. World Journal of Gastroenterology, 2011. 17(2): p. 271-272.
  318. Sahebkar, A., Potential mechanisms behind (-)-epigallocatechin-3-gallate protection against cerebral ischemic injury. Journal of Neuroscience Research, 2011. 89(1): p. 1-2.
  319. Sahebkar, A., Baicalin as a potentially promising drug for the management of sulfur mustard induced cutaneous complications: A review of molecular mechanisms. Cutaneous and Ocular Toxicology, 2012. 31(3): p. 226-234.
  320. Sahebkar, A., Effects of resveratrol supplementation on plasma lipids: A systematic review and meta-analysis of randomized controlled trials. Nutrition Reviews, 2013. 71(12): p. 822-835.
  321. Sahebkar, A., Head-to-head comparison of fibrates versus statins for elevation of circulating adiponectin concentrations: A systematic review and meta-analysis. Metabolism: Clinical and Experimental, 2013. 62(12): p. 1876-1885.
  322. Sahebkar, A., Erratum to Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome? [International Union of Biochemistry and Molecular Biology, 39, 2, (2013) 197-208]. BioFactors, 2013. 39(5): p. 591.
  323. Sahebkar, A., Fat lowers fat: Purified phospholipids as emerging therapies for dyslipidemia. Biochimica et Biophysica Acta – Molecular and Cell Biology of Lipids, 2013. 1831(4): p. 887-893.
  324. Sahebkar, A., Does PPARγ<inf>2</inf> gene Pro12Ala polymorphism affect nonalcoholic fatty liver disease risk? Evidence from a meta-analysis. DNA and Cell Biology, 2013. 32(4): p. 188-198.
  325. Sahebkar, A., Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome? BioFactors, 2013. 39(2): p. 197-208.
  326. Sahebkar, A., Proprotein convertase subtilisin/kexin type 9: A plausible link between serum resistin levels and cardiovascular events. Angiology, 2014. 65(3): p. 243.
  327. Sahebkar, A., Curcuminoids for the management of hypertriglyceridaemia. Nature Reviews Cardiology, 2014. 11(2).
  328. Sahebkar, A., Effect of niacin on endothelial function: A systematic review and meta-analysis of randomized controlled trials. Vascular Medicine (United Kingdom), 2014. 19(1): p. 54-66.
  329. Sahebkar, A., Curcuminoids for the management of hypertriglyceridaemia. Nature reviews. Cardiology, 2014. 11(2): p. 123.
  330. Sahebkar, A., A systematic review and meta-analysis of randomized controlled trials investigating the effects of curcumin on blood lipid levels. Clinical Nutrition, 2014. 33(3): p. 406-414.
  331. Sahebkar, A., Low-density lipoprotein is a potential target for curcumin: Novel mechanistic insights. Basic and Clinical Pharmacology and Toxicology, 2014. 114(6): p. 437-438.
  332. Sahebkar, A., Circulating levels of proprotein convertase subtilisin kexin type 9 are elevated by fibrate therapy: A systematic review and meta-analysis of clinical trials. Cardiology in Review, 2014. 22(6): p. 306-312.
  333. Sahebkar, A., Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? evidence from a meta-analysis. Phytotherapy Research, 2014. 28(5): p. 633-642.
  334. Sahebkar, A., Beyond anti-PCSK9 therapies: The potential role of resistin inhibitors. Nature Reviews Cardiology, 2014. 11(1): p. 12.
  335. Sahebkar, A., A systematic review and meta-analysis of the effects of pycnogenol on plasma lipids. Journal of Cardiovascular Pharmacology and Therapeutics, 2014. 19(3): p. 244-255.
  336. Sahebkar, A., Dual effect of curcumin in preventing atherosclerosis: The potential role of pro-oxidant-antioxidant mechanisms. Natural Product Research, 2015. 29(6): p. 491-492.
  337. Sahebkar, A., The promise of curcumin-phosphatidylcholine complex for cardiometabolic diseases: More than just more curcumin. Natural Product Research, 2015. 29(5): p. 392-393.
  338. Sahebkar, A., Effect of L-carnitine supplementation on circulating C-reactive protein levels: A systematic review and meta-analysis. Journal of Medical Biochemistry, 2015. 34(2): p. 151-159.
  339. Sahebkar, A., Therapeutic potential of negatively charged liposomes for atherosclerotic vascular disease: Reverse delivery of cholesterol cargo from atheroma to liver. Journal of Liposome Research, 2015. 25(2): p. 174.
  340. Sahebkar, A., Curcumin: A Natural Multitarget Treatment for Pancreatic Cancer. Integrative Cancer Therapies, 2016. 15(3): p. 333-334.
  341. Sahebkar, A., Autophagic activation: A key piece of the puzzle for the curcumin-associated cognitive enhancement? Journal of Psychopharmacology, 2016. 30(1): p. 93-94.
  342. Sahebkar, A., Effects of quercetin supplementation on lipid profile: A systematic review and meta-analysis of randomized controlled trials. Critical Reviews in Food Science and Nutrition, 2017. 57(4): p. 666-676.
  343. Sahebkar, A., et al., Mustard lung and COPD: Common features and treatment? The Lancet Respiratory Medicine, 2015. 3(10): p. 747-748.
  344. Sahebkar, A., et al., A simple and effective approach for the treatment of dyslipidemia using anionic nanoliposomes. Colloids and Surfaces B: Biointerfaces, 2014. 122: p. 645-652.
  345. Sahebkar, A., et al., Apolipoprotein B-100-targeted negatively charged nanoliposomes for the treatment of dyslipidemia. Colloids and Surfaces B: Biointerfaces, 2015. 129: p. 71-78.
  346. Sahebkar, A. and M. Banach, Response letter: Management of statin-induced myopathies: Much demands and still (almost) empty hands! Journal of Cachexia, Sarcopenia and Muscle, 2017. 8(3): p. 514-515.
  347. Sahebkar, A., et al., Nigella sativa (black seed) effects on plasma lipid concentrations in humans: A systematic review and meta-analysis of randomized placebo-controlled trials. Pharmacological Research, 2016. 106: p. 37-50.
  348. Sahebkar, A., et al., Impact of statin therapy on plasma levels of plasminogen activator inhibitor-1: A systematic review and meta-analysis of randomised controlled trials. Thrombosis and Haemostasis, 2016. 116(1): p. 162-171.
  349. Sahebkar, A., G.T. Chew, and G.F. Watts, New peroxisome proliferator-Activated receptor agonists: Potential treatments for atherogenic Dyslipidemia and non-Alcoholic fatty liver disease. Expert Opinion on Pharmacotherapy, 2014. 15(4): p. 493-503.
  350. Sahebkar, A., G.T. Chew, and G.F. Watts, Recent advances in pharmacotherapy for hypertriglyceridemia. Progress in Lipid Research, 2014. 56(1): p. 47-66.
  351. Sahebkar, A., et al., Curcumin downregulates human tumor necrosis factor-α levels: A systematic review and meta-analysis ofrandomized controlled trials. Pharmacological Research, 2016. 107: p. 234-242.
  352. Sahebkar, A., et al., Effect of monoclonal antibodies to PCSK9 on high-sensitivity C-reactive protein levels: A meta-analysis of 16 randomized controlled treatment arms. British Journal of Clinical Pharmacology, 2016. 81(6): p. 1175-1190.
  353. Sahebkar, A. and S.A. Emami, Medicinal Plants for the Treatment of Uterus Inflammation: Implications from Iranian Folk Medicine. JAMS Journal of Acupuncture and Meridian Studies, 2013. 6(1): p. 1.
  354. Sahebkar, A., et al., Effects of pomegranate juice on blood pressure: A systematic review and meta-analysis of randomized controlled trials. Pharmacological Research, 2017. 115: p. 149-161.
  355. Sahebkar, A., et al., Impact of statin therapy on plasma resistin and visfatin concentrations: A systematic review and meta-analysis of controlled clinical trials. Pharmacological Research, 2016. 111: p. 827-837.
  356. Sahebkar, A., R. Giua, and C. Pedone, Impact of statin therapy on plasma leptin concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials. British Journal of Clinical Pharmacology, 2016. 82(6): p. 1674-1684.
  357. Sahebkar, A., et al., Fibrate therapy and flow-mediated dilation: A systematic review and meta-analysis of randomized placebo-controlled trials. Pharmacological Research, 2016. 111: p. 163-179.
  358. Sahebkar, A., et al., Effects of supplementation with pomegranate juice on plasma C-reactive protein concentrations: A systematic review and meta-analysis of randomized controlled trials. Phytomedicine, 2016. 23(11): p. 1095-1102.
  359. Sahebkar, A., M. Hassanzadeh-Khayyat, and M. Iranshahi, Qualitative analysis of the hydro-distilled essential oil of ferula latisecta rech. F. and aell. roots from Iran. Journal of Essential Oil-Bearing Plants, 2010. 13(3): p. 340-346.
  360. Sahebkar, A. and Y. Henrotin, Analgesic efficacy and safety of curcuminoids in clinical practice: A systematic review and meta-analysis of randomized controlled trials. Pain Medicine (United States), 2016. 17(6): p. 1192-1202.
  361. Sahebkar, A., et al., Systematic review and meta-analysis deciphering the impact of fibrates on paraoxonase-1 status. Metabolism: Clinical and Experimental, 2016. 65(5): p. 609-622.
  362. Sahebkar, A. and M. Iranshahi, Biological activities of essential oils from the genus Ferula (Apiaceae). Asian Biomedicine, 2010. 4(6): p. 835-847.
  363. Sahebkar, A. and M. Iranshahi, Cancer chemoprevention by 7-Prenyloxycoumarins: A role for 5-Lipoxygenase inhibition? Integrative Cancer Therapies, 2010. 9(3): p. 259-260.
  364. Sahebkar, A. and M. Iranshahi, Volatile constituents of the genus ferula (apiaceae): A review. Journal of Essential Oil-Bearing Plants, 2011. 14(5): p. 504-531.
  365. Sahebkar, A., et al., Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials. Atherosclerosis, 2015. 241(2): p. 433-442.
  366. Sahebkar, A., et al., MicroRNA-33 Inhibition: A potential adjunct to statin therapy? Current Vascular Pharmacology, 2016. 14(4): p. 321-322.
  367. Sahebkar, A., et al., Curcuminoids modulate pro-oxidant-antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals. Phytotherapy Research, 2013. 27(12): p. 1883-1888.
  368. Sahebkar, A., et al., Association of single nucleotide polymorphisms in the gene encoding platelet endothelial cell adhesion molecule-1 with the risk of myocardial infarction: A systematic review and meta-analysis. Thrombosis Research, 2013. 132(2): p. 227-233.
  369. Sahebkar, A. and Y. Panahi, Hyssop (Hyssopus officinalis L.): a potential treatment for mustard lung. Focus on Alternative and Complementary Therapies, 2016. 21(1): p. 68.
  370. Sahebkar, A., et al., Effects of statin therapy on augmentation index as a measure of arterial stiffness: A systematic review and meta-analysis. International Journal of Cardiology, 2016. 212: p. 160-168.
  371. Sahebkar, A., et al., A systematic review and meta-analysis of controlled trials on the effects of statin and fibrate therapies on plasma homocysteine lev. Current Medicinal Chemistry, 2016. 23(39): p. 4490-4503.
  372. Sahebkar, A., et al., Does statin therapy reduce plasma VEGF levels in humans? A systematic review and meta-analysis of randomized controlled trials. Metabolism: Clinical and Experimental, 2015. 64(11): p. 1466-1476.
  373. Sahebkar, A., V. Ponzo, and S. Bo, Effect of dipeptidyl peptidase-4 inhibitors on plasma adiponectin: A systematic review and meta-analysis of randomized controlled trials. Current Medicinal Chemistry, 2016. 23(13): p. 1356-1369.
  374. Sahebkar, A., et al., A cross-sectional study of the association between heat shock protein 27 antibody titers, pro-oxidant-antioxidant balance and metabolic syndrome in patients with angiographically-defined coronary artery disease. Clinical Biochemistry, 2011. 44(17-18): p. 1390-1395.
  375. Sahebkar, A., et al., Statin impact on disease activity and C-reactive protein concentrations in systemic lupus erythematosus patients: A systematic review and meta-analysis of controlled trials. Autoimmunity Reviews, 2016. 15(4): p. 344-353.
  376. Sahebkar, A., et al., Statin therapy and plasma cortisol concentrations: A systematic review and meta-analysis of randomized placebo-controlled trials. Pharmacological Research, 2016. 103: p. 17-25.
  377. Sahebkar, A., et al., Effect of extended-release niacin on plasma lipoprotein(a) levels: A systematic review and meta-analysis of randomized placebo-controlled trials. Metabolism: Clinical and Experimental, 2016. 65(11): p. 1664-1678.
  378. Sahebkar, A., et al., Impact of statin therapy on plasma vitamin D levels: A systematic review and meta-analysis. Current Pharmaceutical Design, 2017. 23(6): p. 861-869.
  379. Sahebkar, A., et al., Curcumin: An effective adjunct in patients with statin-associated muscle symptoms? Journal of Cachexia, Sarcopenia and Muscle, 2017. 8(1): p. 19-24.
  380. Sahebkar, A., et al., Novel circulating biomarkers for non-alcoholic fatty liver disease: A systematic review. Journal of Cellular Physiology, 2018. 233(2): p. 849-855.
  381. Sahebkar, A., et al., Association between statin use and plasma d-dimer levels: A systematic review and meta-analysis of randomised controlled trials. Thrombosis and Haemostasis, 2015. 114(3): p. 546-557.
  382. Sahebkar, A., et al., Effect of garlic on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of randomized controlled clinical trials. Nutrition, 2016. 32(1): p. 33-40.
  383. Sahebkar, A., et al., The impact of statin therapy on plasma levels of von Willebrand factor antigen: Systematic review and meta-analysis of Randomised placebo-controlled trials. Thrombosis and Haemostasis, 2016. 115(3): p. 520-532.
  384. Sahebkar, A., et al., Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors – Results from a systematic review and meta-analysis of randomized controlled trials. International Journal of Cardiology, 2015. 189(1): p. 47-55.
  385. Sahebkar, A., et al., Lipid-modifying effects of nutraceuticals: An evidence-based approach. Nutrition, 2016. 32(11-12): p. 1179-1192.
  386. Sahebkar, A., et al., Head-to-head comparison of statins versus fibrates in reducing plasma fibrinogen concentrations: A systematic review and meta-analysis. Pharmacological Research, 2016. 103: p. 236-252.
  387. Sahebkar, A., et al., The Effects of Tamoxifen on Plasma Lipoprotein(a) Concentrations: Systematic Review and Meta-Analysis. Drugs, 2017. 77(11): p. 1187-1197.
  388. Sahebkar, A., et al., Effect of curcuminoids on oxidative stress: A systematic review and meta-analysis of randomized controlled trials. Journal of Functional Foods, 2015. 18: p. 898-909.
  389. Sahebkar, A., et al., Statin therapy and plasma vitamin E concentrations: A systematic review and meta-analysis of randomized placebo-controlled trials. Atherosclerosis, 2015. 243(2): p. 579-588.
  390. Sahebkar, A., et al., Lipid profile changes after pomegranate consumption: A systematic review and meta-analysis of randomized controlled trials. Phytomedicine, 2016. 23(11): p. 1103-1112.
  391. Sahebkar, A., et al., Effect of statin therapy on plasma proprotein convertase subtilisin kexin 9 (PCSK9) concentrations: A systematic review and meta-analysis of clinical trials. Diabetes, Obesity and Metabolism, 2015. 17(11): p. 1042-1055.
  392. Sahebkar, A., et al., Efficacy and safety of evacetrapib for modifying plasma lipids: A systematic review and meta-analysis of randomized controlled trials. Current Pharmaceutical Design, 2016. 22(5): p. 595-608.
  393. Sahebkar, A., et al., Effects of orlistat on blood pressure: A systematic review and meta-analysis of 27 randomized controlled clinical trials. Journal of the American Society of Hypertension, 2017.
  394. Sahebkar, A., et al., Statin therapy and plasma free fatty acids: A systematic review and meta-analysis of controlled clinical trials. British Journal of Clinical Pharmacology, 2016. 81(5): p. 807-818.
  395. Sahebkar, A., et al., Statistical vs clinical significance: A matter of debate for orlistat treatment. Pharmacological Research, 2017. 124: p. 158-159.
  396. Sahebkar, A., et al., Effect of orlistat on plasma lipids and body weight: A systematic review and meta-analysis of 33 randomized controlled trials. Pharmacological Research, 2017. 122: p. 53-65.
  397. Sahebkar, A., et al., Supplementation with coenzyme Q<inf>10</inf>reduces plasma lipoprotein(a) concentrations but not other lipid indices: A systematic review and meta-analysis. Pharmacological Research, 2016. 105: p. 198-209.
  398. Sahebkar, A., et al., Impact of fibrate therapy on plasma plasminogen activator inhibitor-1: A systematic review and meta-analysis of randomized controlled trials. Atherosclerosis, 2015. 240(1): p. 284-296.
  399. Sahebkar, A., et al., Comparison of the effects of fibrates versus statins on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of head-to-head randomized controlled trials. BMC Medicine, 2017. 15(1).
  400. Sahebkar, A., et al., A systematic reviewandmeta-analysis of randomized controlled trials investigating the effects of supplementationwith Nigella sativa (black seed) on blood pressure. Journal of Hypertension, 2016. 34(11): p. 2127-2135.
  401. Sahebkar, A. and G.F. Watts, New therapies targeting apoB metabolism for high-risk patients with inherited dyslipidaemias: What can the clinician expect? Cardiovascular Drugs and Therapy, 2013. 27(6): p. 559-567.
  402. Sahebkar, A. and G.F. Watts, Fibrate therapy and circulating adiponectin concentrations: Asystematic review and meta-analysis of randomized placebo-controlled trials. Atherosclerosis, 2013. 230(1): p. 110-120.
  403. Sahebkar, A. and G.F. Watts, New LDL-cholesterol lowering therapies: Pharmacology, clinical trials, and relevance to acute coronary syndromes. Clinical Therapeutics, 2013. 35(8): p. 1082-1098.
  404. Sahebkar, A. and G.F. Watts, Role of selective peroxisome proliferator-activated receptor modulators in managing cardiometabolic disease: Tale of a roller-coaster. Diabetes, Obesity and Metabolism, 2014. 16(9): p. 780-792.
  405. Sahebkar, A. and G.F. Watts, Managing recalcitrant hypercholesterolemia in patients on current best standard of care: Efficacy and safety of novel pharmacotherapies. Clinical Lipidology, 2014. 9(2): p. 221-233.
  406. Sahebkar, A. and G.F. Watts, Challenges in the treatment of hypertriglyceridemia: Glass half empty or half full? Expert Review of Clinical Pharmacology, 2015. 8(4): p. 363-366.
  407. Sahebkar, A. and G.F. Watts, Developing role of microRNA-33 in lipid metabolism and atherosclerosis. Current Opinion in Lipidology, 2016. 27(2): p. 197-199.
  408. Sahebkar, A. and G.F. Watts, Mode of action of berberine on lipid metabolism: A new-old phytochemical with clinical applications? Current Opinion in Lipidology, 2017. 28(3): p. 282-283.
  409. Sajed, H., A. Sahebkar, and M. Iranshahi, Zataria multiflora Boiss. (Shirazi thyme) – An ancient condiment with modern pharmaceutical uses. Journal of Ethnopharmacology, 2013. 145(3): p. 686-698.
  410. Salahshooh, M.M., et al., The effect of curcumin (Curcuma longa L.) on circulating levels of adiponectin in patients with metabolic syndrome. Comparative Clinical Pathology, 2017. 26(1): p. 17-23.
  411. Salarbashi, D., et al., Oil stability index and biological activities of Achillea biebersteinii and Achillea wilhelmsii extracts as influenced by various ultrasound intensities. Industrial Crops and Products, 2014. 55: p. 163-172.
  412. Salarbashi, D., et al., Investigation of optimal extraction, antioxidant, and antimicrobial activities of Achillea biebersteinii and A. wilhelmsii. Pharmaceutical Biology, 2012. 50(9): p. 1168-1176.
  413. Salarinia, R., et al., Epi-drugs and epi-mirs: Moving beyond current cancer therapies. Current Cancer Drug Targets, 2016. 16(9): p. 773-788.
  414. Serban, C., et al., Effects of supplementation with green tea catechins on plasma C-reactive protein concentrations: A systematic review and meta-analysis of randomized controlled trials. Nutrition, 2015. 31(9): p. 1061-1071.
  415. Serban, C., et al., Effect of sour tea (Hibiscus sabdariffa L.) on arterial hypertension: A systematic review and meta-analysis of randomized controlled trials. Journal of Hypertension, 2015. 33(6): p. 1119-1127.
  416. Serban, C., et al., A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations. Scientific Reports, 2015. 5.
  417. Serban, M.C., et al., A systematic review and meta-analysis of the impact of Spirulina supplementation on plasma lipid concentrations. Clinical Nutrition, 2016. 35(4): p. 842-851.
  418. Serban, M.C., et al., Impact of L-carnitine on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of randomized controlled trials. Scientific Reports, 2016. 6.
  419. Serban, M.C., et al., Effects of Quercetin on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of the American Heart Association, 2016. 5(7).
  420. Shabgah, A.G., et al., Interleukin-22 in human inflammatory diseases and viral infections. Autoimmunity Reviews, 2017. 16(12): p. 1209-1218.
  421. Shafiee, M., et al., Saffron in the treatment of depression, anxiety and other mental disorders: Current evidence and potential mechanisms of action. Journal of Affective Disorders, 2017. 227: p. 330-337.
  422. Shahabipour, F., et al., Novel approaches toward the generation of bioscaffolds as a potential therapy in cardiovascular tissue engineering. International Journal of Cardiology, 2017. 228: p. 319-326.
  423. Shahabipour, F., M. Banach, and A. Sahebkar, Exosomes as nanocarriers for siRNA delivery: Paradigms and challenges. Archives of Medical Science, 2016. 12(6): p. 1324-1326.
  424. Shahabipour, F., et al., Exosomes: Nanoparticulate tools for RNA interference and drug delivery. Journal of Cellular Physiology, 2017. 232(7): p. 1660-1668.
  425. Shahabipour, F., et al., Naturally occurring anti-cancer agents targeting EZH2. Cancer Letters, 2017. 400: p. 325-335.
  426. Shakeri, A., et al., Identification and biological activity of the volatile compounds of Glycyrrhiza triphylla Fisch. &amp; C.A.Mey. Microbial Pathogenesis, 2017. 109: p. 39-44.
  427. Shakeri, A., et al., Chemical composition, antibacterial activity, and cytotoxicity of essential oil from Nepeta ucrainica L. spp. kopetdaghensis. Industrial Crops and Products, 2014. 58: p. 315-321.
  428. Shakeri, A., et al., Volatile composition, antimicrobial, cytotoxic and antioxidant evaluation of the essential oil from Nepeta sintenisii Bornm. Industrial Crops and Products, 2016. 84: p. 224-229.
  429. Shakeri, A. and A. Sahebkar, Anti-cancer products from marine sponges: Progress and promise. Recent Patents on Drug Delivery and Formulation, 2015. 9(3): p. 187-188.
  430. Shakeri, A. and A. Sahebkar, Nanotechnology: A successful approach to improve oral bioavailability of phytochemicals. Recent Patents on Drug Delivery and Formulation, 2016. 10(1): p. 4-6.
  431. Shakeri, A. and A. Sahebkar, Phytosome: A fatty solution for efficient formulation of phytopharmaceuticals. Recent Patents on Drug Delivery and Formulation, 2016. 10(1): p. 7-10.
  432. Shakeri, A. and A. Sahebkar, Optimized curcumin formulations for the treatment of Alzheimer’s disease: A patent evaluation. Journal of Neuroscience Research, 2016. 94(2): p. 111-113.
  433. Shakeri, A., A. Sahebkar, and B. Javadi, Melissa officinalis L. – A review of its traditional uses, phytochemistry and pharmacology. Journal of Ethnopharmacology, 2016. 188: p. 204-228.
  434. Simental-Mendía, L.E., et al., Impact of curcumin on the regulation of microRNAs in colorectal cancer. Expert Review of Gastroenterology and Hepatology, 2017. 11(2): p. 99-101.
  435. Simental-Mendía, L.E., et al., Effect of soy isoflavone supplementation on plasma lipoprotein(a) concentrations: A meta-analysis. Journal of Clinical Lipidology, 2017.
  436. Simental-Mendía, L.E. and A. Sahebkar, Modulation of microRNAs by curcumin in pancreatic cancer. Clinical Nutrition, 2016. 35(6): p. 1585.
  437. Simental-Mendía, L.E., et al., A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control. Pharmacological Research, 2016. 111: p. 272-282.
  438. Simental-Mendía, L.E., et al., Effect of magnesium supplementation on plasma C-reactive protein concentrations: A systematic review and meta-analysis of randomized controlled trials. Current Pharmaceutical Design, 2017. 23(31): p. 4678-4686.
  439. Simental-Mendía, L.E., et al., Effect of magnesium supplementation on lipid profile: a systematic review and meta-analysis of randomized controlled trials. European Journal of Clinical Pharmacology, 2017. 73(5): p. 525-536.
  440. Simental-Mendía, L.E., et al., Effect of fibrates on glycemic parameters: A systematic review and meta-analysis of randomized placebo-controlled trials. Pharmacological Research, 2018.
  441. Sinaei, F., et al., Olfactory loss management in view of Avicenna: Focus on neuroprotective plants. Current Pharmaceutical Design, 2017. 23(22): p. 3315-3321.
  442. Sobhani, Z., et al., Medicinal plants targeting cardiovascular diseases in view of avicenna. Current Pharmaceutical Design, 2017. 23(17): p. 2428-2443.
  443. Stamerra, C.A., et al., Neurocognitive performance after PCSK9 inhibitor therapy: Current state of the evidence. Journal of Neuroscience Research, 2017.
  444. Tara, F., et al., Selenium supplementation and the incidence of preeclampsia in pregnant Iranian women: A randomized, double-blind, placebo-controlled pilot trial. Taiwanese Journal of Obstetrics and Gynecology, 2010. 49(2): p. 181-187.
  445. Tara, F., et al., Prooxidant-antioxidant balance in pregnancy: A randomized double-blind placebo-controlled trial of selenium supplementation. Journal of Perinatal Medicine, 2010. 38(5): p. 473-478.
  446. Tara, F., et al., Selenium supplementation and premature (pre-labour) rupture of membranes: A randomised double-blind placebo-controlled trial. Journal of Obstetrics and Gynaecology, 2010. 30(1): p. 30-34.
  447. Tavallaie, S., et al., Serum vitamin E concentration in Iranian population with angiography defined coronary artery disease. Asian Biomedicine, 2012. 6(1): p. 19-25.
  448. Tavasolian, F., et al., Altered Expression of MicroRNAs in Rheumatoid Arthritis. Journal of Cellular Biochemistry, 2018. 119(1): p. 478-487.
  449. Tayarani-Najaran, Z., et al., A New Document on Smallpox Vaccination. JAMS Journal of Acupuncture and Meridian Studies, 2016. 9(6): p. 287-289.
  450. Teymouri, M., et al., Biological and pharmacological evaluation of dimethoxycurcumin: A metabolically stable curcumin analogue with a promising therapeutic potential. Journal of Cellular Physiology, 2018. 233(1): p. 124-140.
  451. Teymouri, M., et al., Curcumin as a multifaceted compound against human papilloma virus infection and cervical cancers: A review of chemistry, cellular, molecular, and preclinical features. BioFactors, 2017. 43(3): p. 331-346.
  452. Ursoniu, S., et al., Effects of flaxseed supplements on blood pressure: A systematic review and meta-analysis of controlled clinical trial. Clinical Nutrition, 2016. 35(3): p. 615-625.
  453. Ursoniu, S., et al., Lipid-modifying effects of krill oil in humans: Systematic review and meta-analysis of randomized controlled trials. Nutrition Reviews, 2017. 75(5): p. 361-373.
  454. Ursoniu, S., et al., Lipid profile and glucose changes after supplementation with astaxanthin: A systematic review and meta-analysis of randomized controlled trials. Archives of Medical Science, 2015. 11(2): p. 253-266.
  455. Ursoniu, S., et al., The impact of argan oil on plasma lipids in humans: Systematic review and meta-analysis of randomized controlled trials. Phytotherapy Research, 2017.
  456. Valiahdi, S.M., M. Iranshahi, and A. Sahebkar, Cytotoxic activities of phytochemicals from Ferula species. DARU, Journal of Pharmaceutical Sciences, 2013. 21(1).
  457. Vallejo-Vaz, A.J., et al., Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration. Atherosclerosis Supplements, 2016. 22: p. 1-32.
  458. Vallejo-Vaz, A.J., et al., Familial hypercholesterolaemia: A global call to arms. Atherosclerosis, 2015. 243(1): p. 257-259.
  459. Wang, H., et al., Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet, 2017. 390(10100): p. 1084-1150.
  460. Ward, N., et al., Recent perspectives on the role of nutraceuticals as cholesterol-lowering agents. Current Opinion in Lipidology, 2017. 28(6): p. 495-501.
  461. Yaribeygi, H., et al., Oxidative stress induces renal failure: A review of possible molecular pathways. Journal of Cellular Biochemistry, 2018.
  462. Yaribeygi, H., M.T. Mohammadi, and A. Sahebkar, Crocin potentiates antioxidant defense system and improves oxidative damage in liver tissue in diabetic rats. Biomedicine and Pharmacotherapy, 2018. 98: p. 333-337.
  463. Yaribeygi, H., et al., The impact of stress on body function: A review. EXCLI Journal, 2017. 16: p. 1057-1072.
  464. Yazdanpanah, E., et al., Vitamin D3 Alters the Expression of Toll-like Receptors in Peripheral Blood Mononuclear Cells of Patients With Systemic Lupus Erythematosus. Journal of Cellular Biochemistry, 2017. 118(12): p. 4831-4835.
  465. Yazdanpanah, M.J., et al., Serum zinc and copper status in Iranian patients with pemphigus vulgaris. International Journal of Dermatology, 2011. 50(11): p. 1343-1346.
  466. Zabihi, N.A., et al., Is there a role for curcumin supplementation in the treatment of non-alcoholic fatty liver disease? The data suggest yes. Current Pharmaceutical Design, 2017. 23(7): p. 969-982.
  467. Zamani, Z., et al., Serum Metabolomic Profiling of Sulphur Mustard-Exposed Individuals Using1HNuclear Magnetic Resonance Spectroscopy. Basic and Clinical Pharmacology and Toxicology, 2016. 118(1): p. 77-82.
  468. Zeraati, A.A., et al., The relationship between serology of hepatitis e virus with liver and kidney function in kidney transplant patients. EXCLI Journal, 2016. 15: p. 343-349.

Selected abstracts in international meetings/symposia

  1. Aryanpour, R., et al., Ineffectiveness of simvastatin therapy on serum HSP-60/65 and-70 levels in dislipidemic patients. Clinical Biochemistry, 2011. 44(13): p. S167-S168.
  2. Assali, A., et al., Association of angiotensin II type 1 receptor gene A1166C polymorphism with the presence of diabetes mellitus in patients with documented coronary artery disease. Clinical Biochemistry, 2011. 44(13): p. S3-S3.
  3. Avan, A., et al., Curcumin oleoresin inhibits cell growth and migratory properties of breast cancer cells through inhibition of NF-kB pathway. Annals of Oncology, 2016. 27.
  4. Avan, A., et al., Molecular mechanisms involved in the synergistic interaction of novel formulated curcumin with gemcitabine in pancreatic cancer cells. Annals of Oncology, 2016. 27.
  5. Banach, M., et al., A systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in hiv-infected patients. European Heart Journal, 2016. 37: p. 341-341.
  6. Banach, M., et al., Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology-intravascular ultrasound studies. European Heart Journal, 2015. 36: p. 261-261.
  7. Banach, M., et al., Futility of supplementation with Coenzyme Q10 for statin-induced myopathy: an updated (2015) meta-analysis of randomized controlled trials. European Heart Journal, 2015. 36: p. 1047-1047.
  8. Banach, M., et al., COMPARISON OF CLINICAL OUTCOMES BETWEEN BIORESORBABLE VASCULAR STENTS VERSUS CONVENTIONAL DRUG-ELUTING AND METALLIC STENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS. Journal of the American College of Cardiology, 2016. 67(13): p. 57-57.
  9. Bashi, D.S., et al., Antioxidant and antimicrobial activities of yarrow (Achillea biebersteinii and A. wilhelmsii) extract obtained by ultrasound-assisted extraction method. Clinical Biochemistry, 2011. 44(13): p. S354-S354.
  10. Bashi, D.S., et al., Investigation of biological activities of Achillea biebersteinii and A. wilhelmsii extracts. Clinical Biochemistry, 2011. 44(13): p. S354-S354.
  11. Brie, D., et al., Antihypertensive and anti-inflammatory effects of pentoxifylline? A Systematic review and meta-analysis of randomized controlled trials. European Heart Journal, 2016. 37: p. 339-339.
  12. Chrusciel, P., et al., Impact of statin therapy on plasma adiponectin concentrations: a systematic review and meta-analysis of 43 randomized controlled trial arms. European Heart Journal, 2016. 37: p. 736-736.
  13. Dinca, M., et al., Does vitamin D supplementation alter plasma adipokine concentrations? a systematic review and meta-analysis of randomized controlled trials. European Heart Journal, 2016. 37: p. 546-547.
  14. Ghayour-Mobarhan, M., et al., ASSOCIATION OF ANTIBODY AGAINST HEAT SHOCK PROTEIN-27 AND PRO-OXIDANT-ANTIOXIDANT BALANCE WITH THE SEVERITY OF CORONARY ARTERY DISEASE AND METABOLIC SYNDROME. Atherosclerosis Supplements, 2011. 12(1): p. 105-105.
  15. Henrotin, Y. and A. Sahebkar, ANALGESIC EFFICACY AND SAFETY OF CURCUMINOIDS IN CLINICAL PRACTICE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. Osteoarthritis and Cartilage, 2015. 23: p. A356-A356.
  16. Kotani, K., et al., Tibolone can decrease lipoprotein(a) concentrations in postmenopausal women: a systematic review and meta-analysis of controlled trials. European Heart Journal, 2015. 36: p. 286-286.
  17. Kotani, K., et al., STATIN THERAPY REDUCES PLASMA ENDOTHELIN-1 CONCENTRATIONS: A META-ANALYSIS OF 15 RANDOMIZED CONTROLLED TRIALS. Atherosclerosis, 2015. 241(1): p. E8-E8.
  18. Michalska-Kasiczak, M., et al., Analysis of Vitamin D Levels in Patients With and Without Statin-induced Myalgia – A Systematic Review and Meta-analysis of 7 Studies with 2416 Patients. Circulation, 2014. 130.
  19. Mohamadi, A., et al., Curcumin effects on blood lipid profile in obese individuals. Clinical Biochemistry, 2011. 44(13): p. S239-S239.
  20. Mouhebati, M., et al., ANTIBODY TITERS TO HEAT SHOCK PROTEIN 27 ARE ELEVATED IN PATIENTS WITH MYOCARDIAL INFARCTION. Atherosclerosis Supplements, 2008. 9(1): p. 152-152.
  21. Panahi, Y., et al., METABOLIC ABNORMALITIES AND ATHEROSCLEROSIS: NASH AND LIVER ABNORMALITIES. LIPID-MODIFYING EFFECTS OF CURCUMIN IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE. Atherosclerosis, 2016. 252: p. E155-E155.
  22. Panahi, Y. and A. Sahebkar, Investigation of the Therapeutic Effects of a Combinational Herbal Product Against Benign Prostate Hyperplasia. European Journal of Pharmaceutical Sciences, 2013. 50: p. E153-E153.
  23. Panahi, Y., et al., Investigation of the lipid-lowering effects of chlorella vulgaris extract as an adjunct to low dose atorvastatin and gemfibrozil. Circulation, 2012. 125(19): p. E912-E912.
  24. Pourghadamyari, H., et al., Association of pro oxidant-antioxidant balance with the severity of coronary artery disease. Clinical Biochemistry, 2011. 44(13): p. S140-S141.
  25. Pourghadamyari, H., et al., Evaluating cardiovascular risk factors among type 2 diabetic and healthy populace. Clinical Biochemistry, 2011. 44(13): p. S138-S139.
  26. Rahsepar, A.A., et al., Comparison of Anti-Heat Shock Protein 27 Antibody Levels Among Several Groups, from Childhood to Indolence. Clinical Biochemistry, 2011. 44(13): p. S155-S155.
  27. Sahebkar, A., et al., Antioxidant activity of essential oils from cupressus species against oxidation of LDL. Circulation, 2012. 125(19): p. E912-E913.
  28. Sahebkar, A., et al., Effects of Curcuminoids Supplementation on Circulating Concentrations of Interleukins. European Journal of Pharmaceutical Sciences, 2013. 50: p. E164-E164.
  29. Sahebkar, A., et al., Promising improvement of sulfur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: Results of a randomized double-blind placebo-controlled trial. Clinical Biochemistry, 2011. 44(13): p. S338-S338.
  30. Sahebkar, A., et al., Investigation of the effects of Chlorella vulgaris as an adjunctive therapy for dyslipidemia: Results of a randomized open-label clinical trial. Clinical Biochemistry, 2011. 44(13): p. S338-S339.
  31. Sahebkar, A., Y. Panahi, and N. Khalili, Beneficial effects of adjunctive therapy with bioavailability-enhanced curcumin in subjects with metabolic syndrome receiving low-dose atorvastatin: A randomized parallel-group trial. European Journal of Pharmaceutical Sciences, 2013. 50: p. E234-E234.
  32. Sahebkar, A., et al., Investigation of the effects of Chlorella vulgaris supplementation in patients with non-alcoholic fatty liver disease: A randomized clinical trial. Clinical Biochemistry, 2011. 44(13): p. S113-S114.
  33. Sahebkar, A., Y. Panahi, and H. Taghipour, ANGIOGRAPHIC AND ANTIOXIDANT CHANGES AFTER SUPPLEMENTATION WITH HERACLEUM PERSICUM EXTRACT: RESULTS OF A RANDOMIZED CONTROLLED TRIAL. Atherosclerosis, 2016. 252: p. E92-E92.
  34. Sahebkar, A., et al., Lack of Efficacy for Atorvastatin Therapy in Aortic Stenosis: A One-Year Follow-Up Trial. Cardiovascular Therapeutics, 2012. 30: p. 24-24.
  35. Sahebkar, A., et al., EFFECT OF SOUR TEA (HIBISCUS SABDARIFFA L.) ON ARTERIAL HYPERTENSION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. Atherosclerosis, 2015. 241(1): p. E190-E191.
  36. Sahebkar, A., et al., EFFECT OF CURCUMINOIDS ON OXIDATIVE STRESS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. Atherosclerosis, 2015. 241(1): p. E189-E190.
  37. Sahebkar, A., et al., Statin therapy reduces von Willebrand factor antigen levels: A systematic review and meta-analysis of randomized placebo-controlled trials. European Heart Journal, 2015. 36: p. 224-224.
  38. Sahebkar, A., et al., LACK OF EFFICACY OF RESVERATROL ON CARDIOVASCULAR PARAMETERS? RESULTS FROM A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. Atherosclerosis, 2015. 241(1): p. E190-E190.
  39. Sahebkar, A., et al., A SYSTEMATIC REVIEW AND META-ANALYSIS COMPARING THE EFFECTS OF STATINS AND FIBRATES ON PLASMA LIPOPROTEIN(A) LEVELS. Atherosclerosis, 2016. 252: p. E124-E124.
  40. Serban, C., et al., Effects of supplementation with green tea catechins on plasma C-reactive protein concentrations: a systematic review and meta-analysis of randomized controlled trials. European Heart Journal, 2015. 36: p. 368-369.
  41. Serban, C., et al., A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE IMPACT OF SPIRULINA SUPPLEMENTATION ON PLASMA LIPID CONCENTRATIONS. Atherosclerosis, 2015. 241(1): p. E191-E191.
  42. Serban, C., et al., ASSOCIATION BETWEEN STATIN USE AND PLASMA D-DIMER LEVELS – A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. Atherosclerosis, 2015. 241(1): p. E199-E199.
  43. Serban, C., et al., A SYSTEMATIC REVIEW AND META-ANALYSIS ON THE EFFECT OF STATINS ON PLASMA ASYMMETRIC DIMETHYLARGININE CONCENTRATIONS. Atherosclerosis, 2015. 241(1): p. E199-E199.
  44. Serban, M.C., et al., HEAD-TO-HEAD COMPARISON OF STATINS VERSUS FIBRATES IN REDUCING PLASMA FIBRINOGEN CONCENTRATIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS. Journal of the American College of Cardiology, 2016. 67(13): p. 624-624.
  45. Serban, M.C., et al., THE EFFECT OF QUERCETIN ON BLOOD PRESSURE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. Journal of the American College of Cardiology, 2016. 67(13): p. 2003-2003.
  46. Vakili, R., et al., Effect of a high dairy diet on serum antibody titres to heat shock protein 27 in overweight and obese children. Hormone Research, 2009. 72: p. 414-414.